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ABSTRACT 
This dissertation sought to examine the effect of exposure to fine particulate matter ambient air 
pollution (PM2.5) on cardiovascular disease and biological pathways linking them. 
In the first manuscript, PM2.5 air pollution was significantly associated with IHD and 
PVD mortality in Allegheny County, PA at a lag of 5 days, for the period 1999-2011. The risk of 
IHD mortality due to PM2.5 was significantly greater for individuals who died outside of a 
hospital or nursing home compared to deaths in the hospital or nursing home.  
In the second manuscript, overall, there were no appreciable effects of short and long-
term exposure to PM2.5 air pollution with regard to biomarkers of cardiovascular risk i.e. CRP, 
WBC count, homocysteine and fibrinogen, after adjusting for demographic and cardiovascular 
risk factors in adult NHANES participants for the period 2001-2008. However, we did find some 
evidence suggesting stronger associations of PM2.5 with biomarkers of cardiovascular risk in 
participants with elements of metabolic syndrome e.g., obesity, diabetes, hypertension and 
smokers. 
In the third manuscript, individuals with preexisting metabolic syndrome compared to 
individuals without preexisting metabolic syndrome, showed a stronger positive response in 
systemic inflammation, as manifested by CRP and WBC count, in association with PM2.5 air 
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pollution (both short term and long term), after adjusting for demographic and cardiovascular 
risk factors in adult NHANES participants for the period 2001-2008  
Further research is warranted to confirm these findings in large cohorts. With one third of 
the U.S. population compromised by metabolic syndrome, the health impact of particulate air 
pollution in this sensitive population is likely to be significant and emphasizes the public health 
importance of this body of work.  
 vi 
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1.0  INTRODUCTION 
According to World Health Organization, globally, 3.7 million deaths were attributable to 
ambient air pollution in 2012. 80 % of these deaths attributable to ambient air pollution were due 
to ischemic heart diseases and stroke[1]. Cardiovascular diseases (CVD) including ischemic 
heart diseases and stroke is a major cause of death in United States (US) and globally. Although, 
rates of deaths attributable to CVD have declined over the years in US, it still accounts for 1 in 
every 3 deaths. The economic burden to society is huge considering that the total direct and 
indirect cost of CVD and stroke in the United States for 2010 is estimated to be $315.4 billion 
[2]. American Heart Association (AHA) in its 2010 statement reported that exposure to short 
term and long term levels of PM2.5 increases risk for CVD morbidity and mortality. Many 
credible pathological mechanisms have been elucidated that support the biological plausibility of 
these findings. These include systemic inflammation, systemic oxidative stress, thrombosis and 
coagulation, systemic and pulmonary arterial blood pressure responses, vascular (including 
endothelial) dysfunction, cardiac ischemia, and heart rate variability/autonomic dysfunction[3]. 
However, the epidemiological evidence that explains these mechanisms is still inconclusive.  
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1.1 PARTICULATE MATTER AMBIENT AIR POLLUTION AND 
CARDIOVASCULAR DISEASE 
Epidemiological studies have consistently demonstrated link between particulate matter (PM) 
ambient air pollution and CVD. In broad term, studies can be separated into those that have 
investigated the health effects of acute and chronic air pollution exposure. Brook et al. (2010) 
extensively reviewed available evidence to study relationship of PM air pollution and CVD. In a 
scientific statement from the AHA, they summarized that there is a small, yet consistent 
association between increased mortality and short term elevations in PM10 and PM2.5. They 
concluded that for every 10 μg/m3 elevation in PM2.5 during the preceding 1 to 5 days, there is 
increase of 0.4% to 1.0% in daily mortality specifically cardiovascular death and for every 10 
μg/m3 elevation in long term average PM2.5 exposure, there is approximate 10 % increase in all-
cause mortality. Mortality risk from CVD was elevated to similar extent, although range was 
very broad. Hospital admissions due to CVD were also elevated in response to daily changes in 
PM levels. They also concluded that there is a strong evidence of PM effect on ischemic heart 
disease, moderate (yet growing) for heart failure &  ischemic stroke and modest or mixed for 
peripheral vascular and cardiac arrhythmia/arrest[3]. 
1.1.1 PM2.5   Ambient Air Pollution and Cardiovascular Mortality 
Several studies have been conducted in Unites States and other parts of world after AHA 
statement in 2010 that examined relationship of PM2.5 exposure with CVD mortality. In a study 
conducted in New York, Ito et al. (2011) found that PM2.5 was associated with CVD mortality in 
the warm season at lag 0 [% Excess Risk (ER) = 2.0 %; 95% confidence interval (CI), 0.7–3.3; 
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per 10 μg/ m3] and lag 1 day (1.9 %; 95% CI, 0.8–3.1) and in the cold season at lag 1 day (1.0%; 
95% CI, –0.1 to 2.2). [4]. Zhou et al. (2011) found significant positive association for cumulative 
effect from lag 0 to 2 days  for PM2.5 for all-cause and cardiovascular mortality in the warm 
season in Detroit, suggesting a role of secondary pollutants; in contrast, Seattle showed positive 
associations in Winter [5].  
Shang et al. (2013) conducted a meta-analysis of time series studies from China, 1990-
2012 and found that each 10 µg/m³ increase in PM2.5 was associated with a 0.38% (95% CI: 0.31, 
0.45) increase in total mortality, a 0.51% (95% CI: 0.30, 0.73) in respiratory mortality, and a 
0.44% (95% CI: 0.33, 0.54) in CVD mortality. The associations for PM10 were similarly 
strong[6]. In 2013, Shah et al. conducted a meta-analysis of global studies conducted during 
1984-2012 that examined relationship of the daily levels of particulate matter and gaseous 
pollutants with heart failure hospitalizations or heart failure mortality. They found that increases 
in particulate matter concentration were associated with heart failure hospitalization or death 
(PM2.5, 2.12% per 10 µg/m³, 95% CI: 1·42–2·82; PM10, 1·63% per 10 µg/m³, 95% CI: 1·20–
2·07). Strongest associations were seen on the day of exposure, with more persistent effects for 
PM2.5[7]. Samoli et al. (2014) conducted meta-regression of time series in 10 European 
Mediterranean metropolitan areas. They found a statistically significant increase in cardiac 
deaths by 1.33% (95% CI: 0.27, 2.40%) for a 10 µg/m³ increase in six days' PM2.5 exposure.   
Stronger effects were observed in the warm season. Atkinson et al. (2014) conducted a meta-
analysis and found that a 10 µg/m³ increment in PM2.5 was associated with a 1.04% (95% CI 
0.52-1.56) increase in the risk of death. However, worldwide, there was substantial regional 
variation (0.25% to 2.08%). The associations for respiratory causes of death were larger than for 
cardiovascular causes, 1.51% (1.01% to 2.01%) vs 0.84% (0.41% to 1.28%)[8]. 
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As of now, three studies have examined the relationship between daily PM2.5 and 
mortality in Pittsburgh. Chock et al. (2000) conducted a time series from period 1989-1991 and 
found statistically significant results for PM10 with daily non-accidental mortality for age < 75 in 
0- lag model. However, due to small signal to noise ratio, they could not credibly ascertain the 
relative association of PM2.5 and mortality [9]. Franklin et al. (2007) in a multicity analysis, 
found statistically significant association between daily lag 1 PM2.5 and all-cause mortality in 
Pittsburgh [10]. In another multicity analysis, Franklin et al. (2008) found overall statistically 
significant association of PM2.5 and non-accidental deaths and CVD mortality, but, Pittsburgh 
specific results were not available[11]. 
1.2 PARTICULATE MATTER AMBIENT AIR POLLUTION AND BLOOD 
MARKERS OF CVD RISK 
The first study to link PM air pollution with blood markers was conducted in Belfast and 
Edinburgh, UK in 1999. This study found that city center PM10 measurements over three days 
were positively associated with C-reactive protein (CRP) (p<0.01), negative correlated with 
fibrinogen (p<0.05) and not associated with white blood cell count (WBC) (p<0.61). However, 
none of the personal exposure estimates averaging over three days were associated with any of 
these outcomes. The variables adjusted for analysis were city, season, temperature, and repeated 
individual measurements. Since 1999, there have been number of epidemiological studies that 
attempted to explain biological mechanism linking particulate air pollution with blood markers 
of systemic inflammation (CRP and WBC), systemic oxidative stress (homocysteine) and 
thrombosis and coagulation (fibrinogen), yet the results are inconclusive. Some of the possible 
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reasons behind inconsistent findings are errors in exposure assessment, different exposure time 
period, difference in PM constituents, relative small sample size and inadequate control of 
confounders.  
1.2.1 Particulate Matter Ambient Air Pollution and C - reactive protein 
CRP is a circulating acute-phase reactant that is increased many-fold during the inflammatory 
response to tissue injury or infection. It is synthesized primarily in the liver and its release is 
stimulated by interleukin 6 (IL-6) and other pro-inflammatory cytokines.[12] CRP is linked to 
the development of cardiovascular diseases [13]. 
Out of all the biomarkers studied in relation to air pollution, CRP is the most extensively 
studied. Li et al. (2012) published a systematic review of effect of particulate matter air pollution 
on CRP, including cross-sectional, longitudinal and randomized crossover trial studies. Except 
one study among adults with type 1 or 2 diabetes that found significant association of 7 day 
mean of PM10 with CRP changes, they reported largely null findings from cross-sectional studied 
reviewed [14-21]. One possible reason for largely null findings suggested by them was intake of 
anti-inflammatory medications among adults. Results from three longitudinal studies conducted 
in occupational settings were positive suggesting high PM exposure levels inducing CRP 
synthesis and large variations of PM level enabling detection of meaningful changes of CRP 
levels [22-24]. Additionally, less likely use of medications that might affect CRP levels in a 
healthy occupational population. However, results were inconsistent from ten longitudinal 
studies conducted among the healthy general population [25-34]  and adults with chronic 
inflammatory conditions like CVD [29, 35-38], COPD [29, 39], diabetes and obesity [30, 40-42]. 
Except one, all other seven randomized crossover trial reported null findings[43]. 
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A total of seven longitudinal studies have been published after Li et al.’s systematic 
review. Out of the four panel studies, only Meier et al. (2014) found positive association [44-47]. 
Meier et al. (2014) found that a 10 μg/ m3 increment in PM2.5 exposure was associated with a 
5.56 % (1.05-10.27) increase in CRP among 18 nonsmoking male highway maintenance workers 
in US [47]. Among three large cohort studies, two found significant association. Bind et al. 
(2012) did not found association among short and intermediate exposure (windows of 4/24 
hours, and 3 to 28 days moving average preceding each subject’s examination) of PM2.5, particle 
number and black carbon and CRP among prospective cohort of 704 subjects from the 
Normative Aging Study[48]. Ostro et al. (2014) conducted analysis of SWAN cohort of 1923 
mid-life women and reported that a 10 μg/m3 increment in annual PM2.5 exposure was associated 
with a 25.5% (95% CI: 10.2, 42.9) increase in CRP [49]. Hennig et al. (2014) analyzed a 
prospective population-based German cohort of 4,793 participants (45-75 years of age) and 
found that a 1 μg/m3 increase in residential long-term total PM2.5  was associated with a 4.53% 
increase in hs-CRP concentration (95% CI: 2.76, 6.33). The CRP was 17.89% (95% CI: 7.66, 
29.09) and 7.96% (95% CI: 3.45, 12.67) higher in association with 1 μg/m3 increases in 
residential long-term traffic- and industry specific PM2.5, respectively[50]. 
Two cross-sectional studies were conducted outside US in specific populations i.e. traffic 
policemen and COPD patients. Zhao et al. (2013) analyzed a cross-section of 101, 25-55 years 
old nonsmoker traffic policemen in Shanghai, China with no cardiopulmonary disease and no 
current medication. They found that PM2.5 exposure is associated with the increases in hs-CRP of 
1.1% (0.6–1.5) [51]. However, Dadvand et al. (2014) did not found clear pattern of associations 
across lags 1–10 prior to blood sampling in 251 clinically stable COPD patients in Barcelona 
metropolitan areas, Spain.[52]. 
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The relationship of PM exposure to CRP has been examined extensively. After, Li et al. 
(2012), seven additional longitudinal studies have been conducted. Out of three longitudinal 
studies of large cohort, two observed positive association of long term PM2.5 exposure. Two 
panel studies of healthy volunteers reported null findings, whereas two panel studies of 
occupational settings reported positive association.   
1.2.2 Particulate Matter Ambient Air Pollution and White Blood Cell 
WBC is an indicator of cellular response to inflammation and considered a potentially useful 
predictor of prevalent or incident CVD, according to the joint scientific statement by the Centers 
for Disease Control and Prevention and the American Heart Association [13]. 
As of now, four panel studies have been conducted examining relationship of particulate 
matter air pollution and WBC count [25, 30-32, 37]. Except Dubowsky et al. (2006), none of 
them found significant association. Dubowsky et al. (2006) analyzed 44 senior citizens (> 60 
years of age) in Missouri, USA. They found positive associations between longer moving 
averages of PM2.5 and WBCs across all participants with a 5.5% (95% CI: 0.10, 11) increase per 
interquartile increase (5.4 μg/m3) of PM2.5 averaged over the previous week. Associations with 
WBC counts remained significantly elevated through the 14-day mean but declined with longer 
moving average. Additionally, WBC counts generally increased with IQR changes in ambient 
Black Carbon (BC) [30]. 
Out of five cross-sectional studies, only two studies i.e. Schwartz et al. (2001) and Chen 
et al. (2008) found significant positive association [14, 19, 53-55]. Schwartz et al. (2001) 
analyzed national sample of US population from NHANES III and found that in single-pollutant 
models, PM10 (Lag 0 and 1 before blood collection) was associated with WBC count. In two-
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pollutant models, PM10 (Lag 0 and 1 before blood collection) remained a significant predictor of 
WBC count controlling for SO2.   For WBC, the OR of being in the top 10% for the same IQR 
change was 1.64 (95% CI; 1.17, 2.30). These results were stable with control for indoor 
exposures, dietary risk factors and serum cholesterol[54]. Chen et al. (2008) also conducted 
secondary analysis of NHANES III and found statistically significant association between WBC 
count and estimated long term PM10 levels (p = 0.035). Participants from the least polluted areas 
(1-year PM10 < 1st quartile cutoff: 27.8 μg/m3) had lower WBC counts than the others 
(difference = 145 x 10(6)/L; 95% CI, 10-281)[55].  
Except two cross-sectional studies that examined long-term PM (specifically PM10) 
exposure, all other studies have only examined short term (up to 7 days before blood collection) 
PM exposure. None of the cross sectional studies have examined PM2.5 exposure. Also, no 
longitudinal analysis of large cohort has been conducted. The results are inconsistent and more 
epidemiological studies are needed to examine this relationship, especially focusing on PM2.5 
exposure.   
1.2.3 Particulate Matter Ambient Air Pollution and Fibrinogen 
Fibrinogen is a circulating glycoprotein that acts at the final step in the coagulation response to 
vascular and tissue injury. It is synthesized in liver and cleared by thrombin to form soluble 
fibrin fragments, which are the most abundant component of blood clots[12].Several prospective 
epidemiological studies have shown independent association of fibrinogen and incident 
cardiovascular disease[13]. 
After CRP, fibrinogen is the most studied biomarkers in relation to particulate air 
pollution. A total of 16 longitudinal studies conducted have largely reported null findings [28, 
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29, 31, 33, 35, 44, 46, 56-58], however two longitudinal studies of large cohort found significant 
positive findings. Ruckerl et al. (2007) analyzed a prospective longitudinal cohort of 1,003 MI 
survivors in six European cities and found that five day cumulative exposure to PM10 (13.5 μg/ 
m3) was associated with increased fibrinogen concentrations (percent change of arithmetic mean, 
0.6; 95% CI, 0.1–1.1). In addition to the effect for the cumulative exposure, they also found 
significant increase for fibrinogen with lag 3 for PM2.5 and PM10 [38]. Bind et al. (2012) 
analyzed a prospective cohort of 704 subjects from the Normative Aging Study  and found that 
an IQR increase in exposure (3-day moving average) was associated with a 2.4% (95% CI; 
0.1,4.81) increase in fibrinogen for particle number and  2.6% (95% CI; 0.9,4.3) increase for BC. 
In contrast, PM2.5 was not associated with fibrinogen [48]. 
Chuang et al. (2007) conducted a panel study among 76 young healthy students aged 18 
to 25 years from a university in Taipei and observed that 1 day average PM10 and 1-3 day 
averages sulfate were positively associated with fibrinogen. None of the other particulate matter 
and its constituents was associated with fibrinogen [27]. Wu et al. (2012) panel study of 40 
healthy college students in Beijing, China and found significant associations with Ca, Na, Mg, 
Ba, Fe, Ti, Co and Cd (p<0.05); no association between particles (i.e. PM10, PM10-2.5, PM2.5) and  
fibrinogen[44]. 
Hildebrandt et al. (2009) conducted a panel study among 38 male patients with chronic 
pulmonary disease during winter 2001/2002 in Germany and found a consistent increase in 
fibrinogen for lag 3 with all particulate pollutants (i.e. UFP, PM10, EC, OC) except for ACP. 
Additionally, the 5-day mean concentrations of UFP demonstrated a positive significant 
association[39]. Huttunen et al. (2012) conducted a panel study of 52 elderly ischemic heart 
disease patients living in the city center of Kotka, Finland and observed statistically significant 
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positive association with PM2.5-10 at lag 1. There was a change of 1.15% (95% CI; 0.18, 2.12) per 
5.37μg/m3 (IQR) [37]. Rückerl et al. (2014) analyzed three panels of non-smoking individuals 
(1) with type 2 diabetes (2) with impaired glucose tolerance (3) with a potential genetic 
predisposition in Augsburg, Germany. They observed small positive associations with lag 3 for 
UFP for the panel with potential genetic susceptibility and small but significant positive 
associations for PM10-2.5, PM10, BC and CO for several lags for the panel of T2D/IGT [59].   
Similar to longitudinal studies, largely null findings were reported from 9 cross-sectional 
studies conducted so far among randomly selected healthy adults [14, 16, 53, 60, 61]. Pekkanen 
et al. (2000) analyzed a cross-section of 7205 office workers in London, UK and observed 
significant associations of PM10 only in the warm season. During warm season, there was 
difference of 3.24% in fibrinogen level (1.29, p<0.05) for an increase in PM10 (lag 1) from 10th 
to 90th percentile (i.e. 33.1 μg/m3) [62]. Schwartz et al. (2001) analyzed national sample of US 
population from NHANES III and found PM10 was associated with fibrinogen in single-pollutant 
models. In two-pollutant models (with NO2); PM10 was also positively associated with 
fibrinogen. The magnitude of the effects was modest [e.g., 13 mg/dL fibrinogen for an IQR 
change in PM10, 95% CI: 4.6, 22.1 mg/dL]. However, the OR of being in the top 10% of 
fibrinogen for the same IQR change was 1.77 (95% CI: 1.26, 2.49). These results were stable 
with control for indoor exposures, dietary risk factors and serum cholesterol [54]. Zeka et al. 
(2006) conducted cross-sectional analysis on 710 subjects of the VA Normative Aging Study 
cohort, USA and observed PN concentration in the prior 48 h was associated with increased 
fibrinogen levels (4.19%; 95% CI: 2.04, 6.34), as were concentrations the week before (2.14%; 
95% CI: 50.05, 4.23). The relative change for 1 SD change in the concentration level to 4 week 
moving average  BC for fibrinogen was 1.78%  (95% CI: 0.19, 3.36). No association was seen 
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with PM2.5 and Sulphate [19]. Hoffmann et al. (2009) analyzed baseline data from prospective 
cohort of 4032 participants from densely populated and highly industrialized Ruhr area, 
Germany. They reported that in the adjusted analysis, a cross-sectional exposure difference of 
3.91 μg/m3 in PM2.5 (interdecile range) was associated with increases in fibrinogen of 3.9% (95% 
CI: 0.3, 7.7) in men, whereas no association found in women. Short-term exposures to air 
pollutants and temperature did not influence the results markedly [20]. 
Emmerechts et al. (2012) analyzed a cross section of 233 diabetic patients in Belgium 
and found that concentrations of fibrinogen correlated positively with PM10 at day-2 and day-3, 
as well as with the mean PM10 concentration over 1 week. Each 10 μg/ m3 increase in the mean 
concentration of PM10 over the preceding week at the patient’s residence elevated fibrinogen 
levels by 4% (95% CI: 1,7) [21]. Dadvand et al. (2014) in cross-section of 251 clinically stable 
COPD patients did not observe a clear pattern of associations across the lags for PM2.5 [52]. 
Broadly, studies have examined short, intermediate and long term exposure. Largely null 
findings have been reported from panel studies of healthy young volunteers. Panel studies 
conducted among susceptible population i.e. cardiopulmonary patients have inconsistent results. 
Three studies have examined intermediate exposure (> 7 days to <12 months), however, only 
one longitudinal study found positive association of particle number with fibrinogen. Out of 
three studies that examined long term exposure (annual average), only one study observed 
positive association between annual average PM exposure and fibrinogen. 
1.2.4 Particulate Matter Ambient Air Pollution and Homocysteine 
Homocysteine is a highly reactive, sulfur-containing amino acid formed as a by-product of the 
metabolism of the essential amino acid methionine. Mechanistic studies have demonstrated that 
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homocysteine may induce vascular damage by promoting platelet activation, oxidative stress, 
endothelial dysfunction, hypercoagulability, vascular smooth muscle cell proliferation, and 
endoplasmic reticulum stress. Recent meta-analyses that included larger numbers of prospective 
studies and/or corrected for regression dilution bias (the intra-individual variability in 
homocysteine levels over follow-up) do show a significant association between homocysteine 
and CVDs.[12] 
As of now, only four studies have been conducted to examine relationship of particulate 
air pollutants and homocysteine. Ren et al. (2010) conducted longitudinal analysis of 1000 white 
non-Hispanic older men (mean age, 72.00 +/- 7.2 yrs.) of The Normative Aging Study cohort 
and found that IQR increases in PM2.5 and BC (7-day moving averages) were associated with 
1.5% (95% CI; 0.2, 2.8) and 2.2% (95% CI; 0.6%, 3.9%) increases in total plasma homocysteine, 
respectively [63]. Wu et al. (2012) conducted a panel study of 40 healthy college students in 
Beijing, China and did not find significant association between cumulative average 
concentrations of PM2.5 and its chemical constituents during the preceding 1 (24 hours) to 6 (144 
hours) days prior to the blood collection and tHCy [44]. 
Bacarelli et al. (2007) conducted a cross-sectional analysis of 1,213 healthy subjects from 
Lombardia, Italy. Overall, they did not found any significant association. However in smokers, 
24-hr PM10 levels were associated with 6.3% (95% CI: 1.3, 11.6) and 4.9% (95% CI: 0.5, 9.6) 
increases in fasting and post methionine-load tHcy, respectively, but no association was seen in 
nonsmokers (p-interaction = 0.005 for fasting and 0.039 for post methionine-load tHcy). For 
smokers, 7-day PM10 was associated with a non-significant 3.3% (95% CI: –1.5, 8.4) increase in 
fasting tHcy and a significant 5.2% (95% CI, 0.8 to 9.8; p < 0.05) increase in PML tHcy [64]. 
Park et al. (2008) analyzed a cross-section of 960 community residing elderly men from The 
 13 
Normative Aging Study cohort and did not found any significant association of PM2.5 with total 
homocysteine. However, statistically significant positive associations of total homocysteine were 
observed with traffic-related particles (black carbon and organic carbon) and this was more 
pronounced in persons with low concentrations of plasma folate and vitamin B12. After 
controlling for all potential confounders, an IQR increase in concurrent day BC (0.66 mg/m3) 
was related to a 3.13% (95% CI, 0.76–5.55%) increase in tHcy. No association was observed 
with sulfate, an indicator of coal combustion particles, or PM2.5 [65]. 
The epidemiological studies conducted have only examined short term (up to 7 days 
before blood collection) PM exposure. More studies are needed for any definite conclusion; 
however it seems that short term PM exposure may be associated with homocysteine, especially 
among smokers and older people. 
1.3 PARTICULATE MATTER AMBIENT AIR POLLUTION AND 
INFLAMMATORY MARKERS (CRP AND WBC) IN ADULTS WITH ELEMENTS OF 
METABOLIC SYNDROME 
Out of six longitudinal studies examining the relationship of particulate matter ambient air 
pollution and CRP in adults with elements of metabolic syndrome, three did not show any 
significant association [40-42]. Dubowsky et al. (2006) in panel study of 44 senior citizens (> 60 
years of age) found that associations between PM2.5 and CRP were consistently, and often 
significantly, elevated among the 8 individuals with diabetes (26 repeated samples), 14 
individuals with obesity (41 repeated samples), and 4 individuals with concurrent diabetes, 
obesity, and hypertension (14 repeated samples). They reported that an IQR (6.1 μg/m3) increase 
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in 5 day mean PM2.5 was associated with 48% increase (95 % CI: 5.3-109) in CRP for persons 
with obesity, 74% increase (95% CI:18-158) for persons with diabetes, and an 81 % increase 
(95% CI:21-172) for persons with obesity, diabetes and hypertension compared with a 12% 
increase (95% CI: -25-67) for individuals without any of these conditions[30]. Rückerl et al. 
(2014) conducted study among three panels of non-smoking individuals (1) with type 2 diabetes 
(2) with impaired glucose tolerance (3) with a potential genetic predisposition in Germany. They 
did not found any clear pattern of association among those who had type 2 diabetes and with 
impaired glucose tolerance. However, for the panel with potential genetic susceptibility, a 
consistent and clear increase in CRP in association with all air pollutants (i.e. UFP, PM10, PM10-
2.5, PM2.5, BC and OC) for lag 0 to 4 and 5-day average exposure was observed [59]. Ostro et al. 
(2014) observed the strongest relation of PM2.5 to CRP among diabetics (72.1%, 95% CI 2.9-
187.8 for a 10 μg/m3 change in PM2.5), and associations greater than 40% were noted for the 
high-age group and several other subgroups such as, high blood pressure, on hormone 
therapy[49].  
Zeka et al. (2006) in a cross-sectional analysis of 710 subjects of the VA Normative 
Aging Study cohort found no statistically important difference for any category of effect 
modifiers ((age (<78, >=78 years); BMI, use of medications i.e. anti-hypertensive and cardiac 
medication and hypertension), however, there was suggestion that older age (78 years or older) 
increased the effect of Particle Number concentrations on CRP levels. A 4-fold difference was 
seen for the association between BC and CRP in the presence of obesity [19]. Emmerechts et al. 
(2012) in a cross sectional sample of 233 diabetic  patients  in Belgium found significant positive 
correlations between PM10 exposure at the patient's residence and CRP concentrations for PM10 
exposure windows within 1 week , with positive but only borderline significant values (0.05 < P 
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< 0.10) for the longer time windows up to 6 months. Each 10 μg/m3 increase in the mean PM10 
concentration over the preceding week at the patient's residence increased the CRP by 23% (95% 
CI: 5–45) [21]. 
Three studies have examined the relationship of particulate matter ambient air pollution 
and WBC count in adults with elements of metabolic syndrome. Chen et al (2008) and 
Emmerechts et al. (2012) found significant association whereas Dubowsky et al. (2006) did not. 
Chen et al. (2008)  reported graded association between PM10 and WBC across subpopulations 
with increasing MS components, with 91 x 106/L difference in WBC for those with no MS 
versus 214, 338, and 461 x 106/L for those with 3, 4, and 5 metabolic abnormalities (trend-test p 
= 0.15) was also noted[55]. Emmerechts et al. (2012) observed that for each 10 μg/m3 increase in 
the mean PM10 concentration over the preceding week at the patient's residence increased the 
WBC by 7% (95% CI: 2,12) [21]. 
1.4 EXPOSURE ASSESSMENT FOR AMBIENT AIR POLLUTION 
Exposure assessment of study participants is one of the most challenging aspects of air pollution 
epidemiology. Over the years, methods for assessment have developed starting from proximity 
based to methods based on air quality networks to more advanced methods relying on personal 
exposure. Broadly, panel studies have relied on fixed site monitoring stations. However, recent 
studies have incorporated personal exposure assessment for better estimates. Individual’s activity 
pattern and fixed site monitors were used to estimate personal exposure of participants in study 
by Seaton at al. (1999)[31]. Sorensen et al. (2003) utilized equipment for personal sampling that 
was placed in a backpack, which the subjects carried or placed nearby when they were indoors 
 16 
[56]. Sullivan et al. (2007) and Delfino et al. (2008) measured exposure at participant’s residence 
(outside of residence) or very close to their residence [29, 57]. 
In case of large prospective cohort and cross-sectional studies, a range of methods have 
been used for exposure assessment. Pekkanen et al. (2000), Steinvil et al. (2008) and Panasevich 
et al. (2009) mainly relied on data from fixed site monitoring network [14, 61, 62]. Liao et al. 
(2005) assigned exposure values equal to county specific daily average pollutant exposures, 
calculated for each pollutant by averaging all available monitor-specific daily averages from all 
operating monitors within a county on any calendar date [53]. Bacarelli et al. (2007) used 
information from monitors located at 53 different sites throughout Lombardia, Italy to identify 
nine different study areas in the region characterized by homogeneous within-area air pollution 
concentrations. Averaged mean hourly concentrations were used for exposure assessment after 
assigning each of the study subjects to one of the nine pollution areas, based on their residence 
[60]. 
Schwartz et al. (2001) and Emmerechts et al. (2012) employed geostatistical methods for 
modelling exposures using inverse distance weighting (IDW) and kriging respectively[21, 54]. 
Generally, kriging is a better method as degree of uncertainty in spatial predictions at un-
sampled sites can be calculated thus indicating where interpolation is less reliable. Also, intrinsic 
nature of kriging model better deals with erroneous local variability, yet poor edge representation 
is still an issue. However, IDW methods are simpler to apply and more suitable where sampling 
network is sparse and errors are assumed to be large [66]. 
Dadvand et al. (2014) used land use regression (LUR) model to obtain spatial estimates 
of pollutants and temporally adjusted for assigning to participants[52]. LUR models are 
relatively inexpensive and provide reliable estimates of traffic related air pollution when 
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adequate land use, transportation and pollution monitoring data are available. The main 
limitation of this method is its area specificity [66]. 
Forbes et al. (2009) estimated annual average background exposure to PM10 and other 
pollutants for each 1 km2 of England from an emission inventory by using air dispersion models 
including the effect of weather conditions [16]. Dispersion models generally rely on Gaussian 
plume equations and have advantage of incorporating both spatial and temporal variation of air 
pollution within a study area without need for dense monitoring networks. The disadvantages of 
this model is relatively costly data input, unrealistic dispersion pattern assumptions, need for 
extensive cross-validation and estimate errors die to temporal mismatches[66]. 
Hoffmann et al. (2009) used the EURAD (European Air Pollution Dispersion) model, a 
dispersion and chemistry transport model to estimate the annual mean values for background 
PM2.5 concentrations on a spatial scale of 5-km grid-cell length and assigned these to the 
addresses of the participants. The EURAD model uses input data from official emission 
inventories on a scale of 1 km2, including industrial sources, household heating, traffic, and 
agriculture data on hourly meteorology and regional topography. Surface concentrations were 
calculated by dispersing emissions in horizontal strata, taking chemical reactivity and transport 
processes into account. From the model output, daily surface concentrations of air pollutants for 
a grid-cell length of 5 km were calculated and validated by comparing the model-derived values 
with measured air pollution data from monitoring sites [20]. Due to their high implementation 
cost, data requirements and 1-km grid resolution, integrated meteorological-emission models 
usage is limited in air pollution epidemiological studies [66]. 
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1.5 BIOLOGICAL MECHANISM OF PARTICULATE MATTER AMBIENT AIR 
POLLUTION AND CADIOVASCULAR DISEASES  
Particulate matter inhalation can lead to cardiovascular disease events by three generalized 
intermediary pathways. These pathways include pathway 1, the pulmonary oxidative stress and 
inflammation leading to systemic oxidative stress and inflammation that further releases pro-
inflammatory mediators (e.g. cytokines, activated immune cells, or platelets) or vasculoactive 
molecules (e.g. ET, possibly histamines or micro particles) from lung based cells; pathway 2, 
systemic ANS imbalance or heart arrhythmia by particle interaction with lung receptors or 
nerves; and pathways 3, translocation of PM and/or its constituents into systemic circulation[1]. 
These pathways represent simplified version of complicated biological processes. There is a 
strong experimental evidence of oxidative stress as a critically important cause and consequence 
of PM-mediated cardiovascular effects at the molecular level. Activation of pathway 2 and 3 
within minutes and hours of PM inhalation leads to ANS imbalance (e.g. elevated BP, 
arrhythmias, and increased platelet aggregation), along with direct effects of circulating PM 
constituents (e.g. vasoconstriction, elevated BP, possibly platelet aggregation). These effects 
would be clinically meaningful in those who are susceptible in terms of vulnerable plaque, 
myocardium or circulation and may be responsible for acute triggering of acute cardiovascular 
events e.g. strokes, arrhythmias and heart failure in these individuals. On the contrary, Pathway 1 
(i.e. systemic inflammation) usually requires longer periods for activation of cellular 
inflammatory response (e.g. activated WBCs, platelets) and increased cytokines expression 
consequentially leading to atherosclerotic plaque vulnerability, enhanced coagulation & 
thrombotic changes, insulin resistance and dyslipidemia. These effects would predispose 
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individuals for future cardiovascular events, especially in those who already have traditional risk 
factors or may expedite acute effects via pathways 2 and 3 of later air pollutant exposures. 
In general, there is a large degree of overlap among mechanisms and timing of 
physiological responses to PM inhalation. Also, response to PM inhalation may vary in relation 
to dosage, duration and chemical constituents of PM. However, there is an indication of strong 
overall mechanistic evidence in favor of pathway 1 (via systemic inflammation) as compared to 
other pathways in animal and human studies (Figure 1). 
 
 
Figure 1: Biological pathways linking PM exposure with CVDsa. 
 
 
 
aReprinted with permission Circulation.2010; 121:2331-2378 ©2010 American Heart Association, Inc. 
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1.6 SUMMARY 
Over the last two decades, numerous studies in the United States and elsewhere have reported a 
positive relation between particulate air pollution and CVD morbidity and mortality. The 
epidemiologic evidence that explains biological mechanism behind this positive relationship 
comes from studies of blood markers of systemic inflammation (CRP and WBC), systemic 
oxidative stress (homocysteine) and thrombosis and coagulation (fibrinogen) and other blood 
markers in relation to particulate air pollution. However, due to errors in exposure assessment, 
different exposure time period, difference in PM constituents, relative small sample size and 
inadequate control of confounders, the findings of these studies are inconsistent. Thus, the results 
of my study that utilizes a large representative sample of US population with exposure 
assessment consistent with large populations at different lag periods may provide evidence of 
biological mechanism by which particulate air pollution is related to CVDs. 
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2.0  SPECIFIC AIMS 
The specific aim and related hypothesis are:  
Specific Aim 1: To examine the short term association of PM2.5 air pollution exposure 
with cardiovascular mortality in Allegheny County, PA. We hypothesize that exposure to PM2.5 
air pollution exposure is positively associated with cardiovascular mortality. 
 
Specific Aim 2: To examine the association of PM2.5 air pollution exposure with 
biomarkers (i.e. CRP, WBC, Fibrinogen and HCY) of cardiovascular risk in adult NHANES 
participants. We hypothesize that exposure to PM2.5 air pollution is positively associated with 
biomarkers of CVD risk 
 
Specific Aim 3: To examine the association of PM2.5 air pollution exposure with 
biomarkers (i.e. CRP, WBC, Fibrinogen and HCY) of cardiovascular risk in adult NHANES 
participants with and without metabolic syndrome. We hypothesize that participants with 
metabolic syndrome have increased response of change in biomarkers to PM2.5 air pollution 
compared to participants without metabolic syndrome. 
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3.0  SHORT-TERM EXPOSURE TO PM2.5 AIR POLLUTION AND 
CARDIOVASCULAR MORTALITY IN ALLEGHENY COUNTY, PA: USING A 
SPATIO-TEMPORAL KRIGING METHOD OF EXPOSURE ASSESSMENT 
3.1 ABSTRACT 
Background and Objectives: Short term exposure to fine particulate matter (PM2.5) has been 
associated with cardiovascular diseases (CVD) mortality in numerous studies. However, findings 
from previous studies in Pittsburgh, Allegheny County, PA do not provide conclusive evidence 
of association of PM2.5 with CVD mortality. Our objective was to estimate the relationship of 
short term exposure to PM2.5 and CVD mortality in Allegheny County for the period 1999-2011. 
We also sought to identify vulnerable population subgroups based on sociodemographic 
characteristics, location at the time of death and time of year (season) of death. 
Methods: We utilized a time-stratified case-crossover design to analyze natural CVD mortality 
and other specific natural CVD mortality outcomes i.e. ischemic heart disease (IHD), acute 
myocardial infarction (AMI), cerebrovascular disease, peripheral vascular disease (PVD), heart 
failure (HF) and cardiac arrhythmias for associations with PM2.5, after adjusting for O3 and 
apparent mean temperature. Stratified analysis was conducted for age, gender, race, education, 
season, and location at the time of death. Results are expressed as the percentage change in risk 
of mortality per 10 µg/m3 increase for PM2.5. 
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Results: We found a significant association of PM2.5 with IHD {(2.1% (95% CI, 0.2 %-4.1%)} 
and PVD {(7.6% (95 % CI, 0%-15.7%)} mortality at lag day 5, adjusting for O3 and apparent 
mean temperature. No significant association of PM2.5 with AMI, cerebrovascular disease, HF or 
cardiac arrhythmia was observed. The risk of IHD mortality due to PM2.5 was significantly 
different for those who died outside (4.9 %; 95 % CI, 1.3%-8.6%) of a hospital (0.8 %; 95 % CI, 
-2.1%-3.7%) or a nursing home (1.3 %; 95 % CI, -2.4%-5.0%). Those who died outside of 
hospital or nursing home mainly consisted of deaths at residence. 
Conclusions: PM2.5 air pollution was significantly associated with IHD and PVD mortality. The 
risk of IHD mortality due to PM2.5 was significantly greater for individuals who died outside of a 
hospital or nursing home compared to deaths in the hospital or nursing home. This may reflect a 
more accurate real time exposure to event phenomenon based on spatiotemporal kriging method 
of exposure assessment at zip code of residence and should be explored further. 
3.2 INTRODUCTION 
Several studies have examined the relationship of short term ambient particulate matter (PM2.5) 
air pollution with cardiovascular disease (CVD) mortality [9, 67-71]. Additionally, many studies 
have evaluated susceptibility (e.g. older people) to CVD mortality associated with short-term 
exposure to (PM2.5) air pollution [70-72]. However, findings from previous studies in Pittsburgh, 
Allegheny County, do not provide conclusive evidence of association of PM2.5 air pollution with 
CVD mortality [9-11]. These studies utilized exposure assessments based on single/limited 
monitors for the region. 
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Allegheny County has made considerable progress in reducing PM2.5 air pollution in last 
decade, however, it is important to examine association of PM2.5 air pollution and CVD mortality 
at current levels of air pollution and evaluate susceptible populations because estimates from 
other places may not be applicable to Allegheny County on account of differences in air 
pollution mixtures, population demographics and other factors. Further, none of the study 
conducted in Pittsburgh, Allegheny County examined the effects of PM2.5 air pollution on CVD 
mortality by individual level characteristics such as age, gender, race, education, location at the 
time of death and time of year (season) of death.  
The objectives of the present study were (1) to estimate the short term association 
between ambient particulate matter (PM2.5) air pollution and cause specific mortality i.e., 
cardiovascular and other CVD outcomes, in Allegheny County, 1999-2011, while considering 
the latency of the association and confounding by ozone (O3) and temperature; and (2) to identify 
vulnerable population subgroups based on sociodemographic characteristics, location at the time 
of death and time of year (season) of death. We utilized case-cross over design to analyze recent 
data (1999-2011) with a time frame of 13 years, to examine CVD mortality and other specific 
CVD mortality outcomes i.e. ischemic heart disease (IHD), acute myocardial infarction, 
cerebrovascular disease, peripheral vascular disease (PVD), heart failure and cardiac 
arrhythmias. Moreover, we employed spatiotemporal kriging at the ZIP Code Tabulation Areas 
(ZCTA) level to most precisely determine exposure levels of PM2.5 and O3. 
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3.3 MATERIALS AND METHODS 
Air Pollution and Weather Data 
ZCTA level estimates of PM2.5and O3 were obtained by spatiotemporal kriging with a product-
sum covariance function using measurements from Air Quality System monitors in Allegheny 
County. The spatiotemporal kriging method has been widely used to interpolate spatiotemporal 
measurements of air pollutants. For a specific predicted point-value, the spatiotemporal kriging 
interpolation combined not only its spatially neighboring monitors but also measurements 
backward and forward within seven days. The overall accuracy of spatiotemporal Kriging was 
evaluated using 10-fold cross-validation. The amount of variance explained by PM2.5and O3 
spatiotemporal kriging prediction models were 74.8 % and 87.9 % respectively. This was mainly 
limited due to less capture of less large-scale spatial variations [73]. 
Meteorological variables (mean air temperature, dew point temperature) were available 
from the Pittsburgh International airport. We calculated apparent air temperature as a 
combination of air temperature and dew point temperature to better take into account health 
effects of hot, humid days. The following formula was used to calculate apparent mean 
temperature: 
Apparent mean temperature (°c) = -2.653 + 0.994*Mean air temperature (°c) + 0.0153*(Dew point temperature (°c)) 2 
 
Mortality Data 
Mortality data for Allegheny County residents were obtained from the Pennsylvania Department 
of Health Vital Statistics Division for January, 1999–December, 2011. Mortality data were 
collected from death certificate information and include, for each death, the date and cause of 
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death (International Classification of Diseases (ICD)-10), sex, age, race, education,  location at 
the time of death, zip code of residence, county and state of death. 
 We classified natural cause mortality data into cardiovascular diseases of the circulatory 
system (ICD-10, I00-I99), ischemic heart disease (ICD-10, I20-I25), acute myocardial infarction 
(ICD-10, I21), cerebrovascular disease (ICD-10, I60-69), peripheral vascular disease (ICD-10, 
I70-79), heart failure (ICD-10, I50) and cardiac arrhythmias (ICD-10, I47-I49). Mortality data 
were categorized by age (<80, and ≥80 years, and missing), educational level (<12, 12, >12 
years, and missing), race (white, black, other, and unknown), location at the time of death 
(hospital, nursing home and outside of hospital or nursing home), and season (cold (October-
March), warm (April-September).  
 
Statistical Analysis 
A case-crossover design was utilized in which each case acts as his or her own control. This 
method offers the advantage of controlling for potential confounding from fixed or slowly 
varying individual-level characteristics. We used time-stratified referent selection, in which time 
is divided into fixed strata and the days in each stratum are considered for referents. Control days 
were matched on the same day of week in the same calendar month and year when a death (i.e., 
case) occurred. Cases had either 3 or 4 control days. 
The PM2.5 effects were examined with single-day (lag 0, 1, 2, 3, 4, 5) and unconstrained 
distributed day lags by cause-specific mortality. Lag 0 represents exposure on the same day as 
death; lag 1 represents exposure on the previous day, and so on, whereas unconstrained 
distributed day lag contains many lagged terms at the same time in model, so for example, the 
unconstrained distributed day lag model for maximum lag 5 will contain all lag terms from lag 0 
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to lag 5.  All models were adjusted for ozone and apparent mean temperature at the same lag as 
PM2.5 in single-day lag model or the same distributed lags in unconstrained distributed day lag 
models. We fitted conditional logistic regression models using PROC PHREG in SAS 9.3 (SAS 
Institute, Cary, NC, USA). Results are expressed as the percentage change in risk of mortality 
per 10 µg/m3 increase for PM2.5. To examine effect modification, we separately fitted models 
with an interaction term for PM2.5and potential effect modifier (age, gender, race, education, 
season, and location at the time of death). 
3.4 RESULTS  
Around 60% of deaths were among individuals who were greater than 80 years of age for most 
of the outcomes except heart failure (75.2%) and cardiac arrhythmia (41.1%).  A greater majority 
of events occurred among females ranging from 51.7%-62.5%. Approximately 90 % were of 
white race and roughly 10 % black for most of the outcomes, except for cardiac arrhythmia 
where blacks were in high proportions (17.5%). In terms of education level, the proportion of 
<12, 12 and >12 years of education were nearly quarter, half and quarter, except for the 
peripheral vascular diseases where around 50 % were >12 years educated.  The majority (43% to 
72%) of deaths occurred at a hospital. 53-55 % of deaths occurred in the cold season for all of 
the outcomes (Table 1). 
The mean level of PM2.5 (µg/m3), O3 (ppb), and apparent mean temperature (°C) were 
13.8, 27.0 and 10.2 respectively for the entire study period. The pollutant levels were higher for 
the warm period compared to the cold period (Table 2). Shown in Table 3 are the distribution of 
the absolute differences between exposure on the case day and average of control days. The 
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correlation between pollutants and apparent mean temperature was low to moderate (Table 4). 
The time series of pollutants, apparent mean temperature and outcomes depict variation over the 
study period (Figure 2). 
We estimated associations between daily concentrations of PM2.5 at the zip code of 
residence and cause specific mortality for single and unconstrained distributed lag models. The 
single lag models were better as compared to distributed lag models because of small Akaike 
Information Criterion (AIC) of the single lag models. For subsequent analyses, we selected the 
single lag with the most certain effect estimate, as determined by the AIC, separately for each 
cause of death. We found significant association of PM2.5 with IHD and PVD mortality at lag 5. 
For every 10 µg/m3 increase in PM2.5 at lag 5, there was a 2.1% (95% CI, 0.2 %-4.1%) increase 
in IHD mortality, whereas, for PVD, there was an increase of 7.6% (95 % CI, 0 %-15.7%), 
adjusting for O3 and apparent mean temperature. There were no statistically significant 
associations of PM2.5 with acute myocardial infraction, cerebrovascular disease, heart failure or 
cardiac arrhythmia (Figures 3 and 4).  
The observed associations between PM2.5 and cause-specific mortality were further 
investigated for effect modification by age, gender, race, education, location at the time of death 
and season. Table 5 shows the percent changes in mortality by cause, PM2.5, and population 
subgroup associated with per 10 µg/m3 increase in PM2.5 for the selected lag. The risk of 
mortality was significantly different for those who died outside (4.9 %; 95 % CI, 1.3%-8.6%) of 
a hospital (0.8 %; 95 % CI, -2.1%-3.7%) or nursing home (1.3 %; 95 % CI, -2.4%-5.0%) for 
ischemic heart disease. Approximately 95% of deaths outside of a hospital or nursing home 
occurred at the residence. Except for this, we did not found any statistically significant 
interactions. However, we did found statistical significant effect estimates in different subgroups 
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for CVD, IHD and PVD mortality. For CVD mortality, the estimates were statistically significant 
for males (2.2%; 95 % CI, 0.1%, 4.4%), whites (1.7%; 95 % CI, 0.1%, 3.2%), outside of hospital 
or nursing home (3.8%; 95 % CI, 0.9%, 6.9%); and warm period (2.2%; 95 % CI, 0.2%, 4.2%). 
For IHD mortality, the estimates were statistically significant for >=80 years old (2.6%; 95 % CI, 
0.1%, 5.2%), whites (2.3%; 95 % CI, 0.2%, 4.3%), outside of hospital or nursing home (4.9%; 
95 % CI, 1.3%, 8.6%); and warm period (3.5%; 95 % CI, 0.7%, 6.5%). For PVD mortality, the 
estimates were statistically significant for male (13.7%; 95 % CI, 1.5%, 27.3%), hospital (11.6%; 
95 % CI, 1.7%, 22.4%); and cold period (13.4 %; 95 % CI, 1.2%, 27.1 %) (Table 5). 
3.5 DISCUSSION 
Our study provides evidence of an association between short term exposure to ambient PM2.5 
(lag 5) and mortality due to IHD and PVD, after adjusting for O3 and apparent mean temperature. 
The risk of dying due to IHD was significantly higher for those who died outside of a hospital or 
nursing home. For CVD mortality, the risk of dying was significant for males, whites, and in 
warm season whereas for IHD mortality, the risk of dying was significant for older, whites, and 
in warm season and for PVD mortality, the risk of dying was significant for males and in cold 
season.  
The health impacts of particulate matter air pollution on mortality may differ for men and 
women primarily due to biological differences (hormonal complement, body size) or daily 
activity patterns. Literature shows weak evidence of higher particulate matter–associated risks 
for women than for men[74]. However, we found higher effect estimates for men compared to 
women for CVD and PVD mortality, although differences in effect estimates between sexes were 
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not statistically significant. Our study results are similar to a study conducted in Sao Paulo, 
Brazil [75]. 
There is strong evidence that older people are more susceptible to effects of air pollution 
[76]. Besides differences in physiology, older people likely have different indoor/outdoor 
activity patterns, occupational exposures, and social networks [76]. In our study, higher effect 
estimates for older people were observed for IHD mortality, though differences in effect 
estimates between older and younger people were not statistically different. 
Evidence shows that exposure to air pollution and health status of populations, differs by 
race, with blacks more susceptible compared to other population groups [77, 78]. Differences in 
air pollution related mortality, similar to other health disparities, could be due to genetic 
differences among racial groups or race may acts as a surrogate marker for socioeconomic status 
among other reasons[79]. Most of the studies that evaluated role of race in impacting mortality 
due to particulate air pollution have found no statistical difference among racial groups [72, 80-
82]. One of the limitation noted was use of simplistic categories of race i.e. % African 
Americans or dichotomous categories (e.g. Black, white) [76].We used racial categories as such 
i.e. white, black, other and unknown (% of other and unknown combined was <1%). In our 
study, higher effect estimates were observed among whites compared to black, others and 
unknown, although like previous studies these differences were not significant.  
Socioeconomic status of an individual could modify particulate matter–associated health 
risks through differences in access to health care, baseline health status, occupational exposures, 
and nutrition. Education is the most commonly studied SES indicator for particulate matter–
associated health risks. There is a suggestive evidence of higher risk of mortality with lower 
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education level [76]. We used education as an indicator for SES and did not found effect 
modification of education on mortality. 
Seasonal differences in particulate matter–associated health risks have been observed in 
various studies [11, 83]. These differences may be due to differences in particulate matter 
constituents, level of exposure due to the rate of ventilation of indoor environments with outdoor 
concentrations, time spent outdoors and interaction between temperature and other weather 
conditions with particulate matter. In a seasonal analysis of particulate matter associated 
mortality, higher effect estimates were observed in spring and summer months in Northeast 
region of US [84].We found higher effects estimates for CVD and IHD mortality in summer 
season compared to winter season, though, differences in effect estimates were not statistically 
different. PM2.5 was associated with CVD mortality in the warm season at lag 0 and lag 1 day 
and in the cold season at lag 1 day in a study conducted in New York [4]. Another study found 
significant positive association for cumulative effect from lags 0 to 2 days for PM2.5 for all-
cause and cardiovascular mortality in the warm season in Detroit; in contrast, Seattle showed 
positive associations in winter [5]. In the present study, risk of PVD mortality was higher and 
significant in winter period. This may be due to increased blood clotting because of cold and 
lower mobility in winter period.  
Previous studies have found that risk of dying from air pollution is higher for deaths 
occurring out of hospital compared with in-hospital deaths [81, 85]. More than a threefold effect 
on all-cause mortality from high concentrations of PM10 was observed for deaths occurring out of 
hospital, when compared with in-hospital deaths, mainly driven by heart disease and stroke [81]. 
In the present study, risk of IHD mortality due to PM2.5 was significantly greater for individuals 
who died outside of a hospital or nursing home compared to deaths in the hospital or nursing 
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home.  This difference may be due to actual differences in exposure to air pollutants, as places 
other than hospital or nursing home may be less protected from ambient air pollution. 
Additionally, individuals at hospital or nursing home have obviously better access to treatment, 
thus alleviating effect of air pollution on mortality. We expect that people dying outside of a 
hospital or nursing home would be from disadvantaged groups e.g. blacks or homeless. These 
subpopulations may have difficulty in accessing timely health care leading to significantly higher 
effect of air pollution on CVD/ IHD mortality. The significantly higher estimates of those who 
died outside hospital or nursing home may be due to more accurate exposure assessment based 
on spatiotemporal kriging method at zip code of residence. 
The present study had a sufficient sample size (except for cardiac arrhythmias) to 
examine multiple outcomes and effect modification by individual level characteristics. The large 
sample size was due to use of mortality data for whole Allegheny County for a time frame of 13 
years. However, there are some limitations in our study. First, there may be exposure 
measurement error due to use of average zip code level exposure estimate for examining air 
pollution associated health risk, instead of individual level estimate. However, compared to 
studies that use a single central monitor for exposure estimate, average zip code level exposure 
estimates are better because they incorporates both spatial and temporal variations. Second, no 
association of PM2.5 air pollution with acute myocardial infarction, cerebrovascular disease, 
heart failure or cardiac arrhythmias were found. This might be due to low predictive power of 
spatiotemporal kriging prediction models used in this study. However, with the same model, we 
were able to detect association for CVD, IHD and PVD mortality.  
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Conclusion 
In summary, the study showed that short term exposure to ambient PM2.5 air pollution was 
significantly associated with IHD and PVD mortality. The risk of IHD mortality due to PM2.5 
air pollution was significantly greater for individuals who died outside of a hospital or nursing 
home compared to deaths in the hospital or nursing home. This may reflect a more accurate real 
time exposure to event phenomenon based on spatiotemporal kriging method of exposure 
assessment at zip code of residence and should be explored further. 
3.6 TABLE AND FIGURES 
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Table 1. Demographics, place and time of cause specific mortality in Allegheny County, PA (1 January 1999- 31 December 2011) 
 Cardiovascular  
Disease   
Ischemic Heart 
Disease 
Acute Myocardial 
Infraction* 
Cerebrovascular disease Heart Failure Peripheral Vascular 
disease 
Cardiac arrhythmia 
 N % N % N % N % N % N % N % 
Total 62515 100 34945 100 11303 100 10116 100 4358  100 2256 100 992 100 
Age (years) 
    <80 
   >=80 
Missing 
 
25545  
36966  
4 
 
40.9 
59.1 
0.0 
 
14920 
20022 
3 
 
42.7 
57.3 
0.0 
 
4919 
6382 
2 
 
43.5 
56.5 
0.0 
 
         3622  
6493 
1 
 
35.8 
64.2 
0.0 
 
1079 
3279 
0 
 
24.8 
75.2 
0 
 
929 
1327 
0 
 
41.2 
58.8 
0 
 
584 
408 
0 
 
58.9 
41.1 
0 
Gender 
    Male 
    Female 
 
28096  
34419  
 
44.9 
55.1 
 
16880 
18065 
 
48.3 
51.7 
 
5132 
6171 
 
45.4 
54.6 
 
3794 
6322 
 
37.5 
62.5 
 
1699 
2659 
 
39.0 
61.0 
 
942 
1314 
 
41.8 
58.2 
 
384 
608 
 
38.7 
61.3 
Race 
   White 
   Black 
   Others 
   Unknown 
 
55739  
6571  
173  
329  
 
89.2 
10.5 
0.3 
0.1 
 
31499 
3332 
96 
18 
 
90.1 
9.5 
0.3 
0.1 
 
10241 
1032 
27 
3 
 
90.6 
9.1 
0.2 
0.0 
 
8952 
1126 
36 
2 
 
88.5 
11.1 
0.4 
0.0 
 
3967 
377 
12 
2 
 
91.0 
8.7 
0.3 
0.1 
 
2039 
210 
5 
2 
 
90.4 
9.3 
0.2 
0.1 
 
815 
174 
2 
1 
 
82.2 
17.5 
0.2 
0.1 
Education ( years) 
   <12 
   12 
  >12 
Missing 
 
15663  
31760  
13597  
1495 
 
25.1 
50.8 
21.8 
2.39 
 
8790 
17820 
7465 
870 
 
25.2 
51.0 
21.4 
2.5 
 
2772 
5921 
2368 
242 
 
24.5 
52.4 
21.0 
2.1 
 
2407 
5187 
2319 
203 
 
23.8 
51.3 
22.9 
2.0 
 
1318 
2064 
864 
112 
 
30.2 
47.4 
19.8 
2.6 
 
62 
612 
1135 
447 
 
2.8 
27.1 
50.3 
19.8 
 
211 
508 
257 
16 
 
21.3 
51.2 
25.9 
1.6 
Location of death  
 Hospital 
 Nursing home 
 Outside of hospital or 
nursing home** 
 
29274 
18116 
15125 
 
46.8 
29.0 
24.2 
 
15105 
9522 
10318 
 
43.2 
27.3 
29.5 
 
6165 
2516 
2622 
 
54.5 
22.3 
23.2 
 
5318 
3826 
972 
 
52.6 
37.8 
9.6 
 
1848 
1867 
643 
 
42.4 
42.8 
14.8 
 
1383 
570 
303 
 
61.3 
25.3 
13.4 
 
723 
116 
153 
 
72.9 
11.7 
15.4 
Location of death 
Hospital, inpatient 
Hospital/ER, outpatient 
Hospital, dead upon 
arrival 
Hospital, unknown 
Nursing Home 
Residence 
Other  
 
22678 
6449 
139 
8 
 
18116 
14363 
762 
 
36.3 
10.3 
0.2 
0.0 
 
29.0 
23.0 
1.2 
 
10442 
4551 
106 
6 
 
9522 
9813 
505 
 
29.9 
13.0 
0.3 
0.0 
 
27.3 
28.1 
1.5 
 
4264 
1849 
48 
4 
 
2516 
2535 
87 
 
37.7 
16.4 
0.4 
0.0 
 
22.3 
22.4 
0.8 
 
5018 
295 
5 
0 
 
3826 
923 
49 
 
49.6 
2.9 
0.1 
0 
 
37.8 
9.1 
0.5 
 
1696 
148 
4 
0 
 
1867 
613 
30 
 
38.9 
3.4 
0.1 
0 
 
42.8 
14.1 
0.7 
 
1126 
252 
4 
1 
 
570 
289 
14 
 
49.9 
11.2 
0.2 
0.0 
 
25.3 
12.8 
0.6 
 
618 
104 
1 
0 
 
116 
146 
7 
 
62.3 
10.5 
0.1 
0 
 
11.7 
14.7 
0.7 
Season 
 Cold 
 Warm 
 
33350  
29165  
 
53.4 
46.7 
 
18659 
16286 
 
53.4 
46.6 
 
6056 
5247 
 
53.6 
46.4 
 
5439 
4677 
 
53.8 
46.2 
 
2319 
2039 
 
53.2 
46.8 
 
1218 
1038 
 
54.0 
46.0 
 
551 
441 
 
55.5 
44.5 
*Mortality due to Acute Myocardial Infraction is a category of Ischemic Heart Disease 
** Outside of hospital or nursing home** (includes mainly deaths at residence) 
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Table 2. Air pollutants levels and apparent mean temperature in Allegheny County, PA (1 January 1999- 31 
December 2011) 
 Entire Year Warm Period Cold Period 
Mean  SD Min Max IQR Mean  SD Min Max IQR Mean  SD Min Max IQR 
PM2.5 (µg/m3) 13.8   7.6 0.8 64.5 8.9 15.7  8.6 1.2 64.5 10.7 12.0 5.8 0.8 49.8 7.4 
 O3 (ppb) 27.0  9.8 0.1 83.3 14.4 32.8 8.1 3.5 83.3 10.8 21.3 7.6 0.1 65.9 10.3 
Apparent Mean 
Temperature 
(°C)  
10.2  11.0 -12.6 35.4 19.3 18.7  7.1 -4.3 35.4 10.1 1.7 7.0 -12.6 25.7 10.0 
 
 
 
Table 3. Distribution of the absolute differences between exposure on case day and average of control days in 
Allegheny County, PA (1 January 1999- 31 December 2011) 
Variable Mean Min 5th  25th 50th 75th  95th  Max 
PM2.5 (µg/m3) 6.0 0.0 0.4 2.2 4.7 8.4 15.7 43.5 
 O3 (ppb) 5.8 0.0 0.4 2.2 4.8 8.2 14.9 36.7 
Apparent 
Mean 
Temperature 
(°C)  
4.6 0.0 0.3 1.9 3.9 6.6 11.6 22.8 
 
 
Table 4. Spearman Correlation between pollutants and apparent mean temperature in Allegheny County, PA 
(1 January 1999- 31 December 2011), N=265064 
 PM2.5  (µg/m3) O3 (ppb) Apparent mean 
temperature (°C) 
PM2.5 (µg/m3) 1.000 0.151 
<.0001 
0.371 
<.0001 
O3 (ppb) 0.151 
<.0001 
1.000 0.532 
<.0001 
Apparent mean 
temperature (°C) 
0.371 
<.0001 
0.532 
<.0001 
1.000 
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Table 5. Effect modification of Association between PM2.5 and mortality by cause of death, adjusting for O3 and apparent mean temperature by 
individual level characteristics and season, in Allegheny County, PA (1 January 1999-31 December 2011) 
 Cardiovascular  Disease 
(Lag5)  
  Ischemic Heart Disease 
(Lag5) 
Acute Myocardial 
Infraction (Lag1) 
Cerebrovascular disease 
(Lag2) 
Heart Failure (Lag2) Peripheral Vascular 
disease (Lag5) 
Cardiac arrhythmia 
(Lag1) 
 %  95 % CI %  95 % CI %  95 % CI %  95 % CI %  95 % CI %  95 % CI %  95 % CI 
Age (years) 
    <80 
   >=80 
Missing 
 
1.4 
1.0 
84.9 
 
-0.8 
-0.8 
-69.6 
 
3.6 
2.9 
1023.3 
 
1.4 
2.6 
576.6 
 
-1.5 
0.1 
-75.4 
 
4.4 
5.2 
18512 
 
0 
0.4 
- 
 
-4.8 
-4 
- 
 
5.1 
4.9 
- 
 
-0.8 
1.7 
- 
 
-6.5 
-2.7 
- 
 
5.2 
6.3 
- 
 
-2.7 
-3.6 
- 
 
-12.9 
-9.5 
- 
 
8.7 
2.7 
- 
 
8.6 
6.6 
- 
 
-2.8 
-3.3 
- 
 
21.4 
17.4 
- 
 
-9.3 
-15 
- 
 
-22.2 
-29.3 
- 
 
5.7 
2.2 
- 
Gender 
    Male 
    Female 
 
2.2 
0.3 
 
0.1 
-1.6 
 
4.4 
2.3 
 
2.7 
1.6 
 
-0.1 
-1.1 
 
5.5 
4.3 
 
2.4 
-1.7 
 
-2.5 
-6 
 
7.5 
2.8 
 
0.7 
0.8 
 
-4.9 
-3.6 
 
6.7 
5.5 
 
-5.1 
-2.2 
 
-13.1 
-8.9 
 
3.6 
4.9 
 
13.7 
3.7 
 
1.5 
-5.8 
 
27.3 
14.1 
 
-19.4 
-6.1 
 
-33.5 
-19.1 
 
-2.3 
9 
Race 
   White 
   Black  
   Others 
   Unknown 
 
1.7 
-2. 
-1 
-13.1 
 
0.1 
-6.8 
-24.6 
-55.9 
 
3.2 
1.7 
29.9 
71.2 
 
2.3 
1.1 
-23 
27.1 
 
0.2 
-4.9 
-49 
-44.8 
 
4.3 
7.4 
16.2 
192.5 
 
0.8 
-6.3 
10.6 
-73.1 
 
-2.6 
-15.9 
-45.9 
-98.8 
 
4.4 
4.4 
125.8 
520.5 
 
1.2 
0.0 
-48.7 
- 
 
-2.6 
-10 
-75.4 
- 
 
5.1 
11.0 
6.7 
- 
 
-3.4 
-2.2 
-97.1 
199.5 
 
-8.8 
-18.5 
-99.9 
-97.5 
 
2.3 
17.3 
4.9 
35765.9 
 
6.2 
26.9 
-32.5 
-46.4 
 
-1.7 
-0.6 
-83.9 
-93.4 
 
14.6 
61.9 
182.3 
334 
 
-10 
-23.6 
- 
- 
 
-20.7 
-43.9 
- 
- 
 
2.3 
4.2 
- 
- 
Education (years) 
   <12 
   12 
  >12 
 Missing 
 
1.5 
0.7 
1.5 
3.7 
 
-1.3 
-1.2 
-1.6 
-5.3 
 
4.4 
2.8 
4.7 
13.4 
 
0.7 
2.7 
1.9 
5.0 
 
-3 
0.0 
-2.2 
-6.5 
 
4.6 
5.5 
6.2 
18 
 
-5.1 
1.1 
3.9 
4.6 
 
-11.3 
-3.4 
-3.4 
-16.6 
 
1.4 
5.8 
11.7 
31.3 
 
-0.9 
0.8 
1.9 
8.7 
 
-7.7 
-4.1 
-5.4 
-15.1 
 
6.5 
5.9 
9.8 
39.2 
 
-4.1 
-5.6 
5.8 
-15.6 
 
-13.1 
-12.8 
-6.5 
-40.6 
 
6 
2.3 
19.6 
19.7 
 
-1.1 
9.1 
14.1 
22.2 
 
-14.2 
-1.5 
-3.3 
-20 
 
14 
20.8 
34.5 
86.5 
 
-9.5 
-14.5 
-8 
2.9 
 
-29.3 
-27.6 
-27.3 
-63.1 
 
15.8 
1 
16.3 
186.8 
Location of death  
 Hospital 
 Nursing home 
 Outside of hospital 
or nursing home* 
 
0.8 
-0.3 
3.8 
 
-1.3 
-2.9 
0.9 
 
2.9 
2.4 
6.9 
 
0.8 
1.3 
4.9 
 
-2.1 
-2.4 
1.3 
 
3.7 
5 
8.6* 
 
0.6 
-6 
4.7 
 
-3.7 
-12.5 
-2.1 
 
5.2 
1.1 
12 
 
-1.4 
5 
-2.7 
 
-6.1 
-0.9 
-13.1 
 
3.5 
11.3 
8.9 
 
-8.5 
3.1 
-8.3 
 
-16 
-5 
-20.8 
 
-0.3 
11.8 
6.2 
 
11.6 
3.2 
-2.4 
 
1.7 
-10.8 
-20.5 
 
22.4 
19.4 
19.8 
 
-11.2 
-4.6 
-20.5 
 
-22.5 
-32.4 
-41.9 
 
1.8 
34.5 
8.7 
Season 
 Cold 
 Warm 
 
0.8 
2.2 
 
-1.4 
0.2 
 
3 
4.2 
 
0.8 
3.5 
 
-2.3 
0.7 
 
3.9 
6.5 
 
0 
-1 
 
-5.2 
-5.7 
 
5.5 
3.9 
 
-0.1 
1.2 
 
-5.7 
-4.0 
 
5.7 
6.6 
 
-4.6 
-3.6 
 
-12.7 
-11.1 
 
4.4 
4.5 
 
13.4 
4.5 
 
1.2 
-6.3 
 
27.1 
16.5 
 
-13.8 
-8.9 
 
-28.5 
-23.4 
 
3.9 
8.3 
*% risk was significantly higher for those who died outside of a hospital or nursing home for Ischemic Heart Disease mortality (P value for interaction <0.05). 
- No estimate for these subgroups either due to no observations or models did not converge
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Figure 2. Time series of pollutants, apparent mean temperature and cardiovascular mortality in Allegheny 
County, PA (1 January 1999-31 December 2011) 
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Figure 3. Association between PM2.5 and  mortality by cause of death in Allegheny County, PA, expressed as 
percentage increase in risk (%) and 95% confidence intervals per 10 µg/m3  in single daily lag0 to lag5 (1 
January 1999-31 December 2011), adjusted for O3 and apparent mean temperature 
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Figure 4. Association between PM2.5 and mortality by cause of death in Allegheny County, PA, expressed as 
percentage increase in risk (%) and 95% confidence intervals per 10 µg/m3  in  unconstrained distributed lag 
models (1 January 1999-31 December 2011), adjusted for O3 and apparent mean temperature 
 40 
4.0  ASSOCIATION OF EXPOSURE TO PARTICULATE MATTER (PM2.5) 
AIR POLLUTION AND BIOMARKERS OF CARDIOVASCULAR DISEASE RISK IN 
ADULT NHANES PARTICIPANTS 
4.1 ABSTRACT 
Background and Objectives: Exposure to particulate matter (PM2.5) is associated with 
increased cardiovascular mortality and morbidity, mediated by a hypothesized biological 
mechanism of systemic inflammation and oxidation. Our objective was to examine the 
association of ambient PM2.5 exposure and markers of systemic inflammation and oxidation in 
adult National Health and Nutrition Examination Survey (NHANES) participants and within 
sensitive subgroups.  
Methods: NHANES data (2001-08) on adult participants were merged with meteorological data 
from CDC WONDER and downscaler modelled air pollution data from the United States 
Environmental Protection Agency for each census tract in the 48 conterminous United States. 
The effects of short term (lags 0 to 3 days  and their averages), and long term (30 & 60 day 
moving average and annual average (anavg)) PM2.5  exposures  on C-reactive protein (CRP, 
n=16160), white blood cells (n=16136), fibrinogen (n=2461) and homocysteine (n=11224) levels  
were analyzed using multiple linear regression, adjusting for age, gender, race, education, body-
mass index (BMI), smoking status, total cholesterol, HDL cholesterol, diabetes, hypertension, 
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history of any cardiovascular disease, maximum apparent temperature and ozone. SAS 
SURVEYREG  was used to account for the complex survey design of NHANES. Stratified 
analyses were conducted for BMI, diabetes, hypertension and smoking status.  
Results: Overall, we found no statistically significant positive associations of either short term or 
long term PM2.5 air pollution for any of the biomarkers after controlling for confounders. 
However, we found evidence suggesting stronger associations in participants with obesity, 
diabetes, hypertension and smokers. For every 10 µg/m3 increase in PM2.5, there was a 
significant increase of (a) 36.9 % (0.1 %, 87.2%) in CRP at anavg PM2.5 (adjusted for short term 
exposure of PM2.5 and O3) among diabetics (b) 2.6 % (0.1 %, 5.1%) in homocysteine at lag 0 
among smokers. 
Conclusions: Although, we found no association between PM2.5 and biomarkers of 
cardiovascular risk in general NHANES participants, there were subgroups that manifested 
increase in markers of systemic inflammation and oxidation to PM2.5 exposure. Further studies 
should concentrate on the impact of PM2.5 on markers of systemic inflammation and oxidation in 
those with multiple pre-existing cardiovascular risk factors. 
4.2 INTRODUCTION 
Numerous epidemiological studies have consistently shown that ambient particulate matter is 
associated with increased risk of cardiovascular mortality and morbidity [3, 54, 86]. Particles less 
than 10 micrometers in diameter (PM10) have primarily been used as an exposure metric of 
particulate air pollution in previous studies [54] . However, fine particles, defined as less than 2.5 
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micrometers in diameter (PM2.5), have a smaller size and can penetrate deeper into the lungs than 
large particles and may therefore be of greater health concern [87-89].   
One of the biological pathways linking particulate matter air pollution exposure with 
cardiovascular mortality and morbidity could be systemic inflammation and oxidative stress [3]. 
C-reactive protein (CRP), white blood cell (WBC) count, homocysteine and fibrinogen are 
markers of systemic inflammation and oxidation associated with cardiovascular diseases [12]. 
Although many studies have examined the association of short term exposure, defined as less 
than 30 days duration, of PM2.5 with CRP and fibrinogen [48, 90], there are few studies 
associating PM2.5 with WBC count [19] and homocysteine [44, 63, 91]. Further, there are only a 
few studies examining long term exposure, defined as greater than equal to 30 days duration, of 
PM2.5 with CRP [49, 50, 90] and fibrinogen [20, 90].  No study has examined the association of 
long term exposure of PM2.5 with WBC count and homocysteine. Therefore, the relationship 
between PM2.5 and biomarkers of cardiovascular risk remain inconclusive.  
To date, two studies have been published that utilized nationwide National Health and 
Nutrition Examination Survey (NHANES) data in order to examine the effects of air pollution on 
biomarkers of cardiovascular risk, where PM10 was the exposure metric of particulate air 
pollution [54, 55]. Schwartz (2001) found positive associations for short term exposure of PM10 
and fibrinogen and WBC counts. Chen et al. (2008) found significant positive association of long 
term PM10 and WBC count. However, to our knowledge, no study has been published examining 
the association of PM2.5 and biomarkers of cardiovascular risk in a large nationally representative 
sample. 
Our objective was to examine the association of ambient air pollution exposure with 
biomarkers of cardiovascular risk (CRP, WBC Count, homocysteine and fibrinogen) in adult 
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NHANES participants using nationally available modeled PM2.5 data. We hypothesized that an 
increase in ambient PM2.5 air pollution exposure would be associated with an increase in 
biomarkers of cardiovascular risk in adult NHANES participants, providing a potential 
explanation of the link between air pollution and cardiovascular disease. 
4.3 MATERIALS AND METHODS 
Health data. We used health data from the NHANES conducted by the National Center for 
Health Statistics of the Centers for Disease Control and Prevention (CDC) for the period 2001-
2008. Details about this survey and the detailed measurement procedures and protocols have 
been described on the NCHS website [92]. In brief, the NHANES followed a complex, stratified, 
and multistage probability sampling of the population of the United States (US), with 
oversampling of minorities (African Americans and Mexican Americans) and the elderly (≥ 60 
years of age). The survey consisted of an extensive household interview followed by a series of 
laboratory and other physical tests administered in a mobile examination center (MEC). Only 
those who completed the household interviews were invited for the MEC examination. Since 
1999, NHANES has been continuously conducted in two year cycles. The survey was approved 
by the Institutional Review Board of the NCHS, and informed consent was obtained before 
participation. NHANES public use data sets were accessed for the four cycles of 2001-02, 2003-
04, 2005-06, and 2007-08. We studied non-pregnant adults age 20 and older for CRP, WBC and 
homocysteine; and adults age 40 and older for fibrinogen.  The data for CRP and WBC count 
were available from 2001 to 2008, homocysteine from 2001 to 2006 and fibrinogen from 2001-
2002. After excluding pregnant women and participants with missing data on biomarkers levels 
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and covariates of interest, there were 16160, 16136, 11224 and 2461 participants included in our 
analysis for CRP, WBC, homocysteine and fibrinogen respectively. 
Markers of Inflammation and covariates. The biomarkers of interest in this study were 
CRP, WBC count, homocysteine, and fibrinogen. In addition to these biomarkers, we also 
obtained data on demographic variables (including age, gender, race/ethnicity, and education) 
and potential risk factors for cardiovascular disease, namely smoking status, body mass index 
(BMI), total cholesterol, HDL cholesterol, self-report of physician diagnosed diabetes, history of 
any cardiovascular diseases (i.e. congestive heart failure, coronary heart diseases, angina/angina 
pectoris, heart attack, stroke) and hypertension. Smoking status was defined as follows: current- 
presently smoking cigarettes or serum cotinine levels were greater than or equal to 10 ng/mL; 
former- have smoked 100 cigarettes in life but currently not smoking; never- had not smoked at 
least 100 cigarettes in life. Hypertension was defined as systolic blood pressure ≥ 140 mmHg, 
diastolic blood pressure ≥ 90 mmHg, or a self-report of current use of antihypertensive 
medication. We also obtained data from NHANES on infections within the last 30 days (cold, 
gastrointestinal illness, flu/pneumonia/ear infection), chronic obstructive pulmonary disease 
(COPD) (includes emphysema and chronic bronchitis), household smoker presence and 
rheumatoid arthritis for conducting sensitivity analyses. 
Ambient air pollution and weather data. Predictions of daily ambient 24-hour average 
PM2.5 (µg/m3) and 8-hour maximum O3 levels (ppb) were obtained from the Environmental 
Protection Agency (EPA) using a downscaling modeling approach [93]. This downscaling 
approach uses Bayesian space-time modeling to combine air monitoring data and gridded 
numerical output from the Community Multi-Scale Air Quality Model (CMAQ ) to produce 
point level daily air pollution predictions to the year 2000 US census tract centroids [94]. Daily 
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predictions of O3 and PM2.5 were obtained from January 1, 2001 – December 31, 2008 at the 
population weighted centroid (centers of population) of each year 2000 US census tract in the 48 
conterminous states [95].   
Meteorological data were obtained from the CDC WONDER North America Land Data 
Assimilation System Daily Air Temperatures and Heat Index (1979-2010) website [96]. Daily 
values of the maximum air temperature and maximum heat index for each county were extracted 
for the time period January 1, 2001 through December 31, 2008. Heat index incorporates both 
temperature and relative humidity and is a better measure on days when air temperature >80 F°. 
Maximum heat index was provided for those days when air temperature was above 80 F° or 
26.7° C.  CDC used a formula by Steadman to calculate the hourly heat index, from which the 
daily maximum heat index was computed [97]. For our analysis, we computed a daily maximum 
apparent air temperature which was defined as the daily maximum heat index if provided; 
otherwise the daily maximum air temperature was used. 
We assembled an environmental database of daily pollution data and meteorological data 
for each census tract in the 48 conterminous United States for the time period January 1, 2001 
through December 31, 2008.  This large database contained predicted values of PM2.5 and O3 at 
the population weighted centroid of each year 2000 US census tract and maximum apparent 
temperature for each county assigned to the appropriate census tract level.  In addition to the 
daily levels (lag 0), we calculated the following for PM2.5 and O3,: the level on the previous day 
(lag 1); two days prior (lag 2); three days prior (lag 3); the average of lags 0 and 1 (lag 0 to 1); 
average of lags 0, 1 and 2 (lag 0 to 2); average of lags 0, 1, 2, and 3 (lag 0 to 3); average of lags 1 
and 2 (lag 1 to 2); and the average of lags 1, 2, and 3 (lag 1 to 3). The following long term 
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averages were also calculated: the average of the 30 days prior (30-day moving average), 60 days 
prior (60-day moving average), and annual average. 
Merging of health and environmental data. The Census tract (11 digit Federal 
Information Processing Standards code) of residence of each individual and the date of the 
NHANES examination were used to merge the NHANES data with the environmental dataset of 
air pollution and weather described above. Thus, each NHANES participant was assigned PM2.5, 
O3, and temperature exposure based on the census tract of residence. 
Statistical analysis. We performed weighted descriptive analyses (mean and standard 
error) for each biomarker overall and also stratified by covariates. We examined exposure to 
ambient PM2.5 as a predictor of each biomarker of interest - CRP, WBC, homocysteine, and 
fibrinogen in separate regression models. CRP and homocysteine were log transformed to 
improve normality and stabilize the variance. The short term effects of PM2.5 were examined. We 
specifically analyzed the effect of PM2.5 on the day of the blood draw (lag 0) as well on the day 
before (lag 1), two days before (lag 2), and three days before (lag 3) and averages of these time 
periods (lag 0 to 1, lag 0 to 2, lag 0 to 3, lag 1 to 2, and lag 1 to 3).  In addition, we examined the 
long term effects of PM2.5 on each biomarker by using the average PM2.5 in the 30 days prior, 60 
days prior and annual average value. We also examined the annual average PM2.5 after adjusting 
for short term effects of air pollution (lag 0 to 3 of PM2.5 and O3). 
We used multiple linear regression models to assess the association of PM2.5 with each 
biomarker and calculated regression estimates for a 10 μg/m3 increase in PM2.5. We adjusted 
regression estimates for selected covariates based on prior biological and epidemiological 
knowledge of major determinants of cardiovascular health. Age, BMI, total cholesterol and HDL 
cholesterol were treated as continuous variables, whereas gender, smoking (current smokers vs 
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never & former smoker), diabetes, hypertension and history of any cardiovascular disease were 
treated as dichotomous variables in the models. Race/ethnicity was categorized as Non-Hispanic 
White, Non-Hispanic Black, Mexican American, and Other Race. Education was categorized as 
1-11th grade, high school grade/GED or some college, and college graduate. Both single 
pollutant and two pollutant models (adjusted for the co-pollutant O3 at the same lag or average as 
PM2.5) were evaluated.  The short term models were adjusted for the same day maximum 
apparent temperature, whereas the long term models were adjusted for the 30 day moving 
average maximum apparent temperature. Quartiles of temperature were used to account for non-
linear relationship of temperature with biomarkers.  
Based on prior studies, we used subgroup analyses to assess effect modification by 
smoking status (current smokers, never and former smoker), BMI (< 30 kg/m2, ≥ 30 kg/m2), self-
report of physician diagnosed diabetes (Yes/No), and hypertension (Yes/ No) [19, 20, 30]. 
Regression estimates were adjusted for O3 and maximum apparent temperature and other 
covariates. 
Sensitivity analyses. Certain medical conditions (e.g. rheumatoid arthritis and COPD), 
acute infections and presence of household smoking have been related to elevated levels of 
inflammatory markers [98-101]. Therefore, we investigated the sensitivity of our results to 
alternate ways of modelling by excluding people with history of (a) rheumatoid arthritis; (b) 
COPD; (c) acute infection in last 30 days; (d) household smoking. We also examined our results 
after controlling for season and year because temperature and pollutants show seasonal and 
yearly trend. 
All statistical analyses were performed using SAS software, version 9.2, Cary, NC, US. 
Descriptive analyses were conducted using PROC SURVEYMEANS and PROC 
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UNIVARIATE. All regression models were run accounting for the complex sampling design of 
the NHANES with the SAS SURVEYREG command by using the sample weights included in 
the datasets. P-values <0.05 of were considered significant. All p-values were 2-tailed.  
4.4 RESULTS  
Table 6 shows the distribution of environmental variables from 2001 to 2008 at the level of 
participant’s address on the day of blood draw. The mean ±standard error of PM2.5 (µg/m3), O3 
(ppb), and maximum apparent temperature (°C) were 11.88±0.37, 42.38 ±0.93, and 22.22±0.46 
respectively. 
Table 7 shows the survey weighted descriptive statistics of biomarkers for non-pregnant 
adult participants, excluding those with missing data on biomarkers levels and covariates of 
interest. Females had higher levels of CRP and fibrinogen and lower levels of homocysteine, 
whereas there were no gender differences in levels of WBC. Blacks had elevated levels of all the 
biomarkers except WBC. Older and less educated participants had raised levels of biomarkers. 
Biomarker levels were elevated in those with hypercholesterolemia, among  current smokers, and 
those with the  presence of diabetes, obesity, hypertension, history of any CVD, rheumatoid 
arthritis, COPD and recent infections (except homocysteine that was higher in former smokers, 
overweight and those without any infections in last 30 days). 
In the complete study group, none of the PM2.5 lags (short term or long term) were 
significantly positively associated for any of the biomarkers in both single pollutant and bi-
pollutant models after adjusting for age, gender, race, education, BMI, smoking status, total 
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cholesterol, HDL cholesterol, diabetes, hypertension, history of any cardiovascular disease, 
maximum apparent temperature and ozone (Figure 5 and 6).  
 
Effect modification by obesity, diabetes, hypertension and smoking 
In subgroup analyses, we found increased response of change in biomarkers in participants who 
had obesity, diabetes, hypertension, and who were smokers, compared to those who did not have 
these cardiovascular risk factors (Figure 7, 8, 9 and 10). In particular, participants with diabetes 
showed consistent increased response across all biomarkers compared to participants without 
diabetes. 
We found some significant and near significant positive associations for diabetic 
participants: (a) for every 10 µg/m3 increase in annual average PM2.5 (adjusted for short term 
exposure of PM2.5 and O3), there was a significant increase of 36.9 % (0.1 %-87.2%) in CRP; (b) 
for every 10 µg/m3 increase in 60 day moving average PM2.5, there was a near significant 
increase of 0.3 x 103 cells /µL (-0.05 x 103 - 0.69 x 103) in WBC count (c) for every 10 µg/m3 
increase at 2 day lag PM2.5, there was a near significant increase of  5 % (-0.2%-10.5%) in 
homocysteine. Also, for smokers, there was a significant increase of 2.6 % (0.1 %-5.1%) in 
homocysteine for every 10 µg/m3 increase at zero day lag PM2.5. 
 
Sensitivity Analysis 
The results of sensitivity analyses excluding people with history of (a) rheumatoid arthritis; (b) 
COPD; (c) acute infection in last 30 days; (d) household smoking were largely similar. Also, 
adjusting for season and year led to similar results (Data not shown). 
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4.5 DISCUSSION 
Our objective was to examine the association of PM2.5 air pollution exposure with biomarkers of 
cardiovascular risk (specifically CRP, WBC, fibrinogen, and homocysteine) in adult NHANES 
participants. Overall, we found no statistically significant positive association of either short term 
or long term PM2.5 air pollution with any of the biomarkers of cardiovascular risk. However, 
participants with obesity, diabetes, hypertension and smoking history showed increased levels of 
cardiovascular biomarkers with increase in PM2.5 exposure, compared to those participants 
without these cardiovascular risk factors. In particular, participants with diabetes showed 
consistent increased response across all biomarkers compared to participants without diabetes. 
Our findings were robust to alternate ways of modelling conducted by excluding people with 
history of (a) rheumatoid arthritis; (b) COPD; (c) acute infection in last 30 days; (d) household 
smoking and to adjustment for season and year. 
 
Short term effects of PM2.5 air pollution on biomarkers 
Our study supports largely null findings of previously conducted research among the general [44, 
45, 48, 50, 90], elderly [48], and COPD [52] populations for short term effects of PM2.5 on CRP. 
In contrast to our study, Meier et al. (2014) reported significant positive association of 15 hour 
averages of PM2.5  on CRP in a panel study of non-smoking male highway maintenance workers 
[47]. Similarly, Zhao et al. (2013), in a cross-section of 101 25-55 years old non-smoking traffic 
policemen with no history of cardiopulmonary disease and no current medication in Shanghai, 
China, showed significant positive association of 24 hour averages of PM2.5 on CRP [51]. In both 
studies, significant positive findings may be due to participants’ regular exposure to very high 
level of air pollution on account of their occupation. 
 51 
In regard to the association of PM2.5 with fibrinogen, in concordance with our study, 
previous investigations of both  general [27, 28, 44, 56, 58, 90, 102], elderly [19, 29, 48], and 
pre-existing COPD [52]  and heart disease [35, 37, 57] populations have reported null 
findings.However, Ruckerl et al. (2007) reported significant positive association of lag 3 PM2.5 in  
a prospective cohort of 1,003 Myocardial Infraction survivors in six European cities. This 
positive finding may be explained by exposure to high levels of air pollution in Myocardial 
Infraction survivors who are susceptible due to previous physiologic insult [38]. 
In regard to the association of PM2.5 with WBC, our study is in agreement with null 
findings of previous studies among young [102], elderly [19, 25, 30], and elderly populations 
with preexisting heart disease [37]. In contrast to our study, Dubowsky et al. (2006) reported 
positive associations of PM2.5 with WBC; these associations increased with longer moving 
average and reached statistical significance for previous moving average of 7 days in a panel 
study of 44 elderly participants. However, similar to our study they reported non-significant 
findings for moving averages larger than 14 days.  
Out of three studies conducted so far examining the association of PM2.5  with 
homocysteine, only Ren et al. (2010) reported significant positive associations of moving 
averages of 5, 6 and 7 days of PM2.5 and homocysteine in the Normative Aging Study cohort of 
1000 elderly non-Hispanic white community residing  men [44, 63, 91]. Our study supports 
otherwise null findings. 
 
Long term effects of PM2.5 air pollution on biomarkers 
The null association of a long term effect of PM2.5 on CRP in our study is in accord with previous 
studies [48, 90] . In contrast to our study, Hennig et al. (2014) and Ostro et al. (2014) reported 
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significant positive association for prior year ambient PM2.5 with CRP. However, similar to our 
study, Hennig et al. (2014)  found no association for 28-day mean PM2.5 .With regard to the 
association between long term effects of PM2.5 on fibrinogen, our findings are consistent with 
three previous US studies [19, 48, 90]. However, Hoffmann et al. (2009) reported significant 
association for men in a cross-sectional study of 4032 participants from the densely populated 
and highly industrialized Ruhr area, Germany [20]. To our knowledge, ours is the first study to 
examine the association of long term PM2.5 exposure on homocysteine and WBC, and we found 
no significant positive association. 
 
Effect modification by obesity, diabetes, hypertension and smoking 
We found suggestive evidence that participants with obesity, diabetes, hypertension and smokers 
experienced larger increase in biomarkers compared to participants without these cardiovascular 
risk factors. In particular, participants with diabetes showed consistently increased response 
across all biomarkers compared to participants without diabetes. This finding is in accord with 
previous studies of short term [30, 59] and long term air pollution [49] and our current 
understanding of susceptible population groups to air pollution [3].  
Using NHANES and PM10, Schwartz (2001) and Chen et al. (2008) found positive 
associations for short term (same day) exposure with fibrinogen and WBC counts; long term (1 
year) exposure and WBC count respectively. However, both studies utilized NHANES III (1989-
1994) participants who lived in urban areas only and the pollutant data from US EPA Air Quality 
System monitors [54, 55]. PM10 levels during this earlier time period (1989-1994) were 
significantly higher (mean PM10 = 35.2 µg/m3)[54].  
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Our findings are in accordance with Balmes et al. (2013), who utilized mixed model 
analysis to evaluate NHANES (2001-2006) participants from both rural and urban area and US 
EPA’s hierarchical Bayesian modeled PM2.5.They reported no significant positive associations 
for both short and long term PM2.5 with CRP and WBC count. However, similar to our findings, 
they also reported larger increase in CRP and WBC count in participants with hypertension 
compared to those without hypertension (Balmes J, Mann J, Navarro K, McKone T, unpublished 
data). 
 
Strengths and limitations 
To our knowledge, this is the first nationwide population-based study examining the association 
of short and long-term exposure to PM2.5 air pollution with biomarkers of cardiovascular risk. 
The PM2.5 exposure was assessed by using pollutant predictions at the population weighted 
centroid of the census tract using downscaling model approach from EPA [93].  This approach 
allows use of health data for nearly the entire country instead of being limited to urban areas due 
to its ability to predict air pollutant concentrations for a large spatial extent and makes study 
findings generalizable to the US.  Additionally, it better predicts temporal variability indicative 
of air pollutant concentrations measured at air quality monitors compared with earlier CMAQ 
models and spatial interpolation methods [93, 103]. Our study was able to consider health effects 
at the lower end of ambient particulate matter exposure compared to previous studies [54] . Our 
study suggests that even at low level of air pollution, those with multiple pre-existing 
cardiovascular risk factors might have an increased risk of cardiovascular disease when exposed 
to particulate matter air pollution.  
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This study must be interpreted in the context of its known limitations. There is a potential 
of exposure misclassification due to less confidence in the pollutant predictions in rural areas 
because of the increasing distance of these locations from air quality monitors [103]. 
Additionally, there is a possibility of error in exposure measurement due to use of average 
population exposure rather than individual exposure estimates and not accounting for the time 
spent indoors vs outdoors by the participants.   
 
Conclusions 
Overall, there were no appreciable effects of short and long-term exposure to PM2.5 air pollution 
with regard to biomarkers of cardiovascular risk after adjusting for demographic and 
cardiovascular risk factors in our nationally representative sample of adult men and women. 
However, we did find some evidence suggesting stronger associations of PM2.5 with biomarkers 
of cardiovascular risk in participants with elements of metabolic syndrome e.g. obesity, diabetes, 
hypertension and smokers. Further studies should concentrate on the impact of PM2.5 on markers 
of systemic inflammation and oxidation in those with multiple pre-existing cardiovascular risk 
factors.    
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4.6 TABLES AND FIGURES 
Table 6. Distribution of environmental variables 
Year N PM2.5(µg/m3) O3 (ppb) Temperature (° C) 
2001 2227 11.02 ± 0.59 41.25 ± 1.53 23.18±1.33 
2002 2130 12.64 ± 1.51 46.06 ± 3.18 23.12±1.19 
2003 2018 12.77 ± 1.08 43.79 ± 2.50 22.18±1.00 
2004 2175 11.32 ± 0.81 38.96 ± 1.82 22.37±1.58 
2005 1893 12.69 ± 0.96 43.35 ± 2.84 21.36±1.40 
2006 2074 10.83 ± 0.68 39.30 ± 1.69 21.23±1.01 
2007 2604 12.80 ± 1.43 44.39 ± 2.84 22.46±1.83 
2008 2667 11.37 ± 0.62 42.83 ± 2.17 21.93±1.22 
2001-2008 17788 11.88 ± 0.37 42.38 ± 0.93 22.22±0.46 
*Values are mean ± SE 
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Table 7. Survey weighted descriptive statistics of biomarkers for non-pregnant adult study participants 
 C-reactive protein White blood cells count Homocysteine Fibrinogen 
 
n (%) 
Mean±SE  
(mg/dL) n (%) 
Mean ± SE 
(103 cells/µL)  n (%) 
Mean ± SE 
(µmol/L) n (%) 
Mean ± SE 
(mg/dL) 
Overall 16160 (100) 0.40±0.01 16136(100) 7.26±0.03 11224(100) 8.80±0.07 2461(100) 368.54±4.74 
Age (years) 
  20-39 
  40-59 
  60+ 
 
5227 (37.4) 
5228 (39.9) 
5705 (22.8) 
 
0.35±0.01 
0.41±0.01 
0.47±0.01 
 
5218(37.4) 
5223(39.9) 
5695(22.8) 
 
7.40±0.04 
7.21±0.05 
7.12±0.04 
 
3686(37.8) 
3611(39.9) 
3927(22.3) 
 
7.72±0.06 
8.79±0.07 
10.66±0.14 
 
         N/A 
1252(67.0) 
1209(33.0) 
 
N/A 
356.20±5.19 
393.57±4.69 
Gender 
   Male 
   Female 
 
8234(49.7) 
7926(50.4) 
 
0.34±0.01 
0.46±0.01 
 
8219(49.6) 
7917(50.4) 
 
7.25±0.04 
7.27±0.04 
 
5782(50.0) 
5442(50.0) 
 
9.45±0.08 
8.16±0.09 
 
1255(49.4) 
1206(50.6) 
 
357.34±5.55 
379.47±4.62 
Race/Ethnicity 
   White 
   Black 
   Hispanic 
   Others 
 
8340(72.6) 
3205(10.5) 
3097(7.6) 
1518(9.3) 
 
0.39±0.01 
0.51±0.02 
0.44±0.02 
0.37±0.02 
 
8326(72.6) 
3202(10.5) 
3096(7.6) 
1512(9.3) 
 
7.32±0.04 
6.59±0.05 
7.48±0.05 
7.37±0.07 
 
5941(73.2) 
2255(10.5) 
2246(7.4) 
782(8.9) 
 
8.96±0.08 
8.94±0.11 
7.58±0.06 
8.39±0.15 
 
1433(78.6) 
429(8.7) 
439(4.2) 
160(8.5) 
 
365.01±5.49 
392.62±4.87 
367.91±2.57 
376.85±5.19 
Education 
   1-11th grade 
   HS grad/GED  
  College graduate 
 
4633(18.1) 
8329(56.0) 
3198(26.0) 
 
0.47±0.02 
0.41±0.01 
0.32±0.01 
 
4622(18.0) 
8319(56.0) 
3195(26.0) 
 
7.54±0.06 
7.35±0.04 
6.88±0.04 
 
3128(17.3) 
5840(56.6) 
2256(26.1) 
 
9.21±0.15 
8.83±0.08 
8.47±0.09 
 
710(17.3) 
1200(53.4) 
551(29.3) 
 
392.64±5.41 
370.69±5.27 
350.39±4.59 
Smoking 
   Never 
   Former 
   Current 
 
8233(51.0) 
4232(24.8) 
3695(24.4) 
 
0.38±0.01 
0.40±0.01 
0.44±0.01 
 
8218(51.0) 
4226(24.7) 
3692(24.4) 
 
6.92±0.03 
7.02±0.05 
8.21±0.06 
 
5654(50.3) 
2984(24.8) 
2586(25.0) 
 
8.39±0.06 
9.28±0.12 
9.17±0.13 
 
1155(48.1) 
835(31.8) 
471(20.1) 
 
363.76±4.05 
367.16±6.05 
382.17±7.35 
BMI 
  <25.0  
  25-29.9  
  >=30.0 
 
4943(33.1) 
5779(34.9) 
5438(32.1 
 
0.26±0.01 
0.35±0.01 
0.60±0.0 
 
4938(33.1) 
5767(34.9) 
5431(32.1) 
 
6.96±0.04 
7.16±0.04 
7.69±0.05 
 
3532(33.6) 
4063(34.9) 
3629(31.5) 
 
8.49±0.09 
9.05±0.08 
8.86±0.10 
 
693(29.3) 
987(38.9) 
781(31.7) 
 
348.88±5.48 
364.05±4.21 
392.23±4.75 
Hypertension 
  Yes 
   No 
 
6006(30.2) 
10154(69.8) 
 
0.49±0.01 
0.36±0.01 
 
5996(30.2) 
10140(69.8) 
 
7.40±0.04 
7.20±0.04 
 
4101(29.8) 
7123(70.2) 
 
10.10±0.10 
8.26±0.07 
 
1177(39.8) 
1284(60.2) 
 
386.76±5.23 
356.52±4.97 
Total Cholesterol (mg/dL) 
  <240  
  >=240  
 
13627(84.2) 
2533(15.8) 
 
0.40±0.01 
0.41±0.01 
 
13606(84.2) 
2530(15.8) 
 
7.23±0.04 
7.45±0.05 
 
9436(83.8) 
1788(16.2) 
 
8.73±0.07 
9.17±0.12 
 
1971(79.9) 
490(20.1) 
 
365.72±5.13 
379.77±4.32 
HDL-Cholesterol (mg/dL) 
  <40  
  40-49  
  50-59  
  >60  
 
3092(19.1) 
4671(28.4) 
3775(23.3) 
4622(29.2) 
 
0.49±0.02 
0.41±0.01 
0.39±0.02 
0.34±0.01 
 
3089(19.2) 
4662(28.4) 
3773(23.3) 
4612(29.2) 
 
7.87±0.06 
7.46±0.05 
7.08±0.05 
6.82±0.04 
 
2011(17.9) 
3289(28.7) 
2637(23.4) 
3287(29.9) 
 
9.05±0.10 
8.98±0.10 
8.65±0.08 
8.61±0.10 
 
500(19.9) 
726(28.8) 
539(22.0) 
696(29.3) 
 
374.45±8.36 
376.00±5.26 
368.10±4.30 
357.56±5.16 
Diabetes 
  Yes 
  No 
 
1763(7.5) 
14397(92.5) 
 
0.57±0.03 
0.39±0.01 
 
1759(7.5) 
14377(92.5) 
 
7.62±0.08 
7.23±0.03 
 
1139(7.1) 
10085(92.9) 
 
10.10±0.20 
8.71±0.07 
 
318(9.5) 
2143(90.5) 
 
399.92±8.63 
365.27±4.61 
History of any CVD 
 Yes 
  No 
 
1867(8.4) 
14293(91.6) 
 
0.57±0.02 
0.39±0.01 
 
1864(8.4) 
14272(91.6) 
 
7.46±0.06 
7.24±0.03 
 
1299(8.4) 
9925(91.6) 
 
11.38±0.26 
8.57±0.06 
 
349(11.0) 
2112(89.0) 
 
403.86±6.76 
364.17±5.04 
Recent Infection  
 Yes 
 No 
 
4104(26.0) 
11273(74.0) 
 
0.53±0.02 
0.36±0.01 
 
4100(26.0) 
11256(74.0) 
 
7.51±0.05 
7.16±0.04 
 
2924(27.1) 
7736(73.0) 
 
8.70±0.12 
8.87±0.06 
 
615(24.3) 
1785(75.7) 
 
375.15±4.48 
366.30±5.33 
Rheumatoid Arthritis 
 Yes 
 No 
 
882(4.1) 
15252(95.9) 
 
0.60±0.03 
0.39±0.01 
 
880(4.1) 
15230(95.9) 
 
7.45±0.13 
7.25±0.03 
 
591(4.1) 
10613(95.9) 
 
9.73±0.28 
8.77±0.06 
 
161(5.0) 
2296(95.01) 
 
402.54±6.75 
366.69±4.80 
COPD 
 Yes 
 No 
 
1233(7.4) 
14880(92.6) 
 
0.61±0.03 
0.38±0.01 
 
1234(7.5) 
14855(92.6) 
 
7.77±0.10 
7.22±0.03 
 
816(7.4) 
10372(92.7) 
 
9.43±0.23 
8.75±0.07 
 
189(7.5) 
2259(92.5) 
 
401.13±7.54 
365.60±4.88 
Household Smoker 
 Yes 
 No 
 
3159(20.0) 
12883(80.0) 
 
0.48±0.02 
0.38±0.01 
 
3157(20.0) 
12861(80.0) 
 
8.07±0.07 
7.06±0.03 
 
2225(20.6) 
8906(79.4) 
 
9.47±0.14 
8.64±0.06 
 
466(19.5) 
1971(80.5) 
 
380.99±7.06 
365.49±4.60 
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Figure 5. Change (95 % CI) in biomarkers for per 10 µg/m3 increase in PM2.5 at different lag times (a) C - 
reactive protein (CRP) (b) White Blood Cell (WBC) counts (c) Homocysteine (d) Fibrinogen. Models are 
adjusted for age, gender, race/ethnicity, education, smoking status, body mass index, total cholesterol, HDL 
cholesterol, diabetes, hypertension, history of any cardiovascular diseases and maximum apparent 
temperature. 
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Figure 6. Change (95 % CI) in biomarkers for per 10 µg/m3 increase in PM2.5 at different lag times (a) C - 
reactive protein (CRP) (b) White Blood Cell (WBC) counts (c) Homocysteine (d) Fibrinogen. Models are 
adjusted for age, gender, race/ethnicity, education, smoking status, body mass index, total cholesterol, HDL 
cholesterol, diabetes, hypertension, history of any cardiovascular diseases, maximum apparent temperature 
and ozone 
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Figure 7. Effect Modification of associations between PM2.5 and C - reactive protein (CRP) by disease 
condition at different lag times. Models are adjusted for age, gender, race/ethnicity, education, smoking 
status, body mass index, total cholesterol, HDL cholesterol, diabetes, hypertension, history of any 
cardiovascular diseases and maximum apparent temperature and ozone. 
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Figure 8. Effect Modification of associations between PM2.5 and White Blood Cell (WBC) counts by disease 
condition at different lag times. Models are adjusted for age, gender, race/ethnicity, education, smoking 
status, body mass index, total cholesterol, HDL cholesterol, diabetes, hypertension, history of any 
cardiovascular diseases and maximum apparent temperature and  ozone. 
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Figure 9. Effect Modification of associations between PM2.5 and Homocysteine by disease condition at 
different lag times. Models are adjusted for age, gender, race/ethnicity, education, smoking status, body mass 
index, total cholesterol, HDL cholesterol, diabetes, hypertension, history of any cardiovascular diseases, 
maximum apparent temperature and ozone. 
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Figure 10. Effect Modification of associations between PM2.5 and Fibrinogen by disease condition at different 
lag times. Models are adjusted for age, gender, race/ethnicity, education, smoking status, body mass index, 
total cholesterol, HDL cholesterol, diabetes, hypertension, history of any cardiovascular diseases, maximum 
apparent temperature and ozone. 
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5.0  SYSTEMIC INFLAMMATORY RESPONSE TO PARTICULATE 
MATTER (PM2.5) AIR POLLUTION AND METABOLIC SYNDROME IN ADULT 
NHANES PARTICIPANTS 
5.1 ABSTRACT 
Background and Objectives: Previous studies suggest that individuals with preexisting cardio 
metabolic disorders may be at particularly increased risk of systemic inflammation by PM2.5 air 
pollution, leading to increased risk of cardiovascular diseases. We investigated potential 
susceptibility of metabolic syndrome (MetS) participants to ambient PM2.5 air pollution as 
suggested by increased markers of systemic inflammation compared to participants without 
MetS in adult National Health and Nutrition Examination Survey (NHANES) participants. 
Methods: NHANES data (2001-08) on adult participants were merged with meteorological data 
from CDC WONDER and downscaler modelled air pollution data from the United States 
Environmental Protection Agency for each census tract in the 48 conterminous United States. 
The effects of short term (lags 0 to 3 and their averages), and long term (30 & 60 day moving 
average (ma) and annual average (anavg)) PM2.5 levels on C-reactive protein (CRP, n=7134) and 
white blood cells count (WBC, n=7123) were analyzed using multiple linear regression, 
adjusting for age, gender, race, education, smoking status, history of any cardiovascular disease, 
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maximum apparent temperature and ozone, for participants with and without MetS. SAS 
SURVEYREG  was used to account for the complex survey design of NHANES.   
Results: : After adjusting for confounders, we generally observed an increase in CRP and WBC 
count with both short and long term ambient PM2.5 air pollution exposure for participants with 
MetS compared to participants without MetS. For every 10 µg/m3change in lag 0 PM2.5, there 
was a significant positive change of 10.1% (95% CI:  2.2%, 18.6%) in CRP for participants with 
MetS, whereas for participants without MetS, change in CRP was - 1.3% (95% CI: 8.8 %, 6.8%). 
There were no significant associations for WBC count. 
Conclusions: These data are consistent with the hypothesis that individuals with preexisting 
metabolic syndrome are susceptible to ambient PM2.5 air pollution as expressed by serum 
markers of systemic inflammation. Further research is warranted to confirm these findings in 
large cohorts. With one third of the U.S. population compromised by MetS, the health impact of 
particulate air pollution in this sensitive population is likely to be significant. 
5.2 INTRODUCTION 
Metabolic syndrome (MetS), defined as a cluster of individual cardiovascular risk factors 
comprised of raised blood pressure, dyslipidemia (raised triglycerides and lowered high-density 
lipoprotein cholesterol), raised fasting glucose, and central obesity,  increases the likelihood of  
cardiovascular disease (CVD) [104-106] and has been associated with systemic inflammation 
[107]. Studies have shown that MetS increases the risk of CVD to an extent greater than that 
conferred by any of its individual components [105, 108, 109]. Individuals with MetS have 
shown greater susceptibility to autonomic dysfunction (e.g. heart rate variability) in response to 
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PM2.5 exposure [110]. Recently, a study reported higher risk of CVD mortality with increased 
levels of long term PM2.5 exposure among participants with preexisting cardio-metabolic 
disorders e.g. diabetes, hypertension [111]. 
Previous studies have shown that the association between particulate matter (PM) 
exposure and systemic inflammation is stronger among participants with diabetes, obesity, and 
hypertension [19, 21, 30, 49]. These findings suggest that individuals with preexisting cardio 
metabolic disorders may be at particularly increased risk of systemic inflammation by PM air 
pollution. [107]. Therefore, it is important to study the effect of PM air pollution on systemic 
inflammation in participants with MetS. This is an important public health issue because of the 
enormous and growing prevalence of MetS worldwide, including one third population of the 
United States, and ubiquitous nature of air pollution. 
Our objective is to use data from the National Health and Nutrition Examination Survey 
(NHANES), a US nationwide survey, to investigate potential susceptibility of MetS participants 
to PM2.5 air pollution for markers of systemic inflammation, i.e., C-reactive protein (CRP) and 
white blood cell (WBC) count compared to participants without MetS. We hypothesized that 
participants with MetS will have increased response of change in biomarkers of cardiovascular 
risk to increase in PM2.5 air pollution compared to participants without MetS. 
5.3 MATERIALS AND METHODS 
Health data. We used health data from the NHANES conducted by the National Center for 
Health Statistics of the Centers for Disease Control and Prevention (CDC) for the period 2001-
08. Details about this survey and the specific measurement procedures and protocols have been 
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described on the NCHS website [92]. In brief, the NHANES followed a complex, stratified, and 
multistage probability sampling of the population of the US, with oversampling of minorities 
(African Americans and Mexican Americans) and the elderly (≥ 60 years of age). The survey 
consisted of an extensive household interview followed by a series of laboratory and other 
physical tests administered in a mobile examination center (MEC). Only those who completed 
the household interviews were invited for the MEC examination. Since 1999, the NHANES has 
been continuously conducted in two year cycles. The survey was approved by the Institutional 
Review Board of the NCHS, and informed consent was obtained before participation. The 
NHANES public use data sets were accessed for the four cycles of 2001-02, 2003-04, 2005-06, 
and 2007-08. We studied non-pregnant adults aged 20 and older having information available on 
all five criteria of MetS. After excluding pregnant women and participants with missing data on 
biomarkers levels and covariates of interest, there were and 7134 and 7123 participants included 
in our analysis for CRP and WBC, respectively. 
Markers of Inflammation and covariates. The biomarkers of interest in this study were 
CRP and WBC count. In addition to these biomarkers, we also obtained data on demographic 
variables (including age, gender, race/ethnicity, and education) and potential risk factors for 
cardiovascular disease, such as smoking status and history of any cardiovascular diseases (i.e. 
congestive heart failure, coronary heart diseases, angina/angina pectoris, heart attack, stroke). 
Smoking status was defined as follows: current-presently smoking cigarettes or serum cotinine 
levels were greater than or equal to 10 ng/mL; former-have smoked 100 cigarettes in life but 
currently not smoking; never-had not smoked at least 100 cigarettes in life. We also obtained 
data from NHANES on infections within the last 30 days (cold, gastrointestinal illness, 
flu/pneumonia/ear infection), chronic obstructive pulmonary disease (COPD) (includes 
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emphysema and chronic bronchitis), household smoker presence and rheumatoid arthritis for 
conducting sensitivity analyses. 
Definition of MetS. MetS was defined as per the Joint Scientific Statement Harmonizing 
the MetS [107]. According to these guidelines, MetS is defined as the presence of three or more 
of the following conditions: high blood pressure, hypertriglyceridemia, low high- density 
lipoprotein cholesterol (HDL-C), elevated fasting glucose, and abdominal obesity. High blood 
pressure was defined as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 
mmHg. For this analysis, high blood pressure could also be defined by a self-report of current 
use of antihypertensive medication. Hypertriglyceridemia was identified based on triglycerides 
≥150 mg/dL. Low HDL-C was identified by HDL-C < 40 mg/dL in men or < 50 mg/dL in 
women. Elevated fasting glucose was defined as fasting glucose ≥100 mg/dL; for this analysis, 
elevated fasting glucose could also be defined by a self-report of current use of insulin or oral 
hypoglycemic. Abdominal obesity was defined based on waist circumference ≥ 102 cm in men 
and 88 cm in women. The details of the adult questionnaire, MEC examination, and laboratory 
tests for profiling MetS risk factors have been described on the NCHS website [92]. 
Ambient air pollution and weather data. Predictions of daily ambient 24-hour average 
PM2.5 (µg/m3) and 8-hour maximum O3 levels (ppb) were obtained from the Environmental 
Protection Agency (EPA) using a downscaling modeling approach [93]. This downscaling 
approach uses Bayesian space-time modeling to combine air monitoring data and gridded 
numerical output from the Community Multi-Scale Air Quality Model (CMAQ ) to produce 
point level daily air pollution predictions to the year 2000 US census tract centroids [94]. Daily 
predictions of O3 and PM2.5 were obtained from January 1, 2001 – December 31, 2008 at the 
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population weighted centroid (centers of population) of each year 2000 US census tract in the 48 
conterminous states [95].   
Meteorological data were obtained from the CDC WONDER North America Land Data 
Assimilation System Daily Air Temperatures and Heat Index (1979-2010) website [96]. Daily 
values of the maximum air temperature and maximum heat index for each county were extracted 
for the time period January 1, 2001 through December 31, 2008. Heat index incorporates both 
temperature and relative humidity and is a better measure on days when air temperature >80 F°. 
Maximum heat index was provided for those days when air temperature was above 80 F° or 
26.7° C.  CDC used a formula by Steadman to calculate the hourly heat index, from which the 
daily maximum heat index was computed [97]. For our analysis, we computed a daily maximum 
apparent air temperature which was defined as the daily maximum heat index if provided; 
otherwise the daily maximum air temperature was used. 
We assembled an environmental database of daily pollution data and meteorological data 
for each census tract in the 48 conterminous United States for the time period January 1, 2001 
through December 31, 2008.  This large database contained predicted values of PM2.5 and O3 at 
the population weighted centroid of each year 2000 US census tract and maximum apparent 
temperature for each county assigned to the appropriate census tract level.  In addition to the 
daily levels (lag 0), we calculated the following for PM2.5 and O3,: the level on the previous day 
(lag 1); two days prior (lag 2); three days prior (lag 3); the average of lags 0 and 1 (lag 0 to 1); 
average of lags 0, 1 and 2 (lag 0 to 2); average of lags 0, 1, 2, and 3 (lag 0 to 3); average of lags 1 
and 2 (lag 1 to 2); and the average of lags 1, 2, and 3 (lag 1 to 3). The following long term 
averages were also calculated: the average of the 30 days prior (30-day moving average), 60 days 
prior (60-day moving average), and annual average. 
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Merging of health and environmental data. The Census tract (11 digit Federal 
Information Processing Standards code) of residence of each individual and the date of the 
NHANES examination were used to merge the NHANES data with the environmental dataset of 
air pollution and weather described above. Thus, each NHANES participant was assigned PM2.5, 
O3, and temperature exposure based on the census tract of residence. 
Statistical analysis. We performed weighted descriptive analyses (mean and standard 
error) for each biomarker overall and also stratified by covariates. We examined exposure to 
ambient PM2.5 as a predictor of each biomarker of interest- CRP and WBC in separate regression 
models. CRP was log transformed to improve normality and stabilize the variance. To evaluate 
the short term effects of PM2.5 we analyzed the effect of PM2.5 on the day of the blood draw (lag 
0) as well on the day before (lag 1), two days before (lag 2), and three days before (lag 3) and 
averages of these time periods (lag 0 to 1, lag 0 to 2, lag 0 to 3, lag 1 to 2, and lag 1 to 3).  In 
addition, we examined the long term effects of PM2.5 on each biomarker by using the average 
PM2.5 in the 30 days prior, 60 days prior and annual average value. We also examined the long 
term effects of PM2.5 after adjusting for short term effects of air pollution (lag 0 to 3 of PM2.5 and 
O3). 
We used multiple linear regression models to assess the association of PM2.5 with each 
biomarker in subgroups: participants with and without MetS. The regression estimates were 
calculated for a 10 μg/m3 increase in PM2.5 after controlling for selected covariates based on prior 
biological and epidemiological knowledge of major determinants of cardiovascular health. Age 
was treated as a continuous variable, whereas gender, smoking (current smokers vs never & 
former smoker) and history of any cardiovascular disease were treated as dichotomous variables 
in the models. Race/ethnicity was categorized as non-Hispanic white, non-Hispanic black, 
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Mexican American, and other race. Education was categorized as 1-11th grade, high school 
grade/GED or some college, and college graduate. Models were run adjusted for the co-pollutant 
O3 at the same lag or average as PM2.5.  Short term models were adjusted for maximum apparent 
temperature at the zero lag. The 30 day and 60 day moving average models were adjusted for 30 
day maximum apparent temperature. The annual average models were not adjusted for 
temperature. Quartiles of temperature were used to account for non-linear relationship of 
temperature with biomarkers.  
 Sensitivity analyses. Certain medical conditions (e.g. rheumatoid arthritis and COPD), 
acute infections and presence of household smoking have been related to elevated levels of 
inflammatory markers [98-101]. Therefore, we investigated the sensitivity of our results to 
alternate ways of modelling by excluding people with history of (a) rheumatoid arthritis; (b) 
COPD; (c) acute infection in last 30 days; (d) household smoking. We also examined our results 
after controlling for season and year because temperature and pollutants show seasonal and 
yearly trend. All statistical analyses were performed using SAS software, version 9.2, Cary, NC, 
US. Descriptive analyses were conducted using PROC SURVEYMEANS and PROC 
UNIVARIATE. 
All statistical analyses were performed using SAS software, version 9.2, Cary, NC, US. 
Descriptive analyses were conducted using PROC SURVEYMEANS and PROC 
UNIVARIATE. All regression models were run accounting for the complex sampling design of 
the NHANES with the SAS SURVEYREG command by using the sample weights included in 
the datasets. P-values <0.05 of were considered significant. All p-values were 2-tailed.  
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5.4 RESULTS 
There were 7408 and 7397 non-pregnant adult participants with information available on all five 
criteria of MetS and CRP or WBC analysis respectively. Out of these, 35.1 % (N=2901 for CRP 
analysis group, N=2894 for WBC analysis group) were defined as having MetS as they met three 
or more criteria per the definition of MetS [107]. 
Table 8 shows the distribution of environmental variables from 2001 to 2008 at the level 
of participant’s address on the day of blood draw. The mean ± standard error of PM2.5 (µg/m3), 
O3 (ppb), and maximum apparent temperature (°C) were 11.74±0.37, 42.47±0.98, and 
22.14±0.48, respectively. 
Table 9 shows the survey weighted descriptive statistics of biomarkers for non-pregnant 
adult participants with information available on all five criteria of MetS, excluding participants 
with missing data on CRP and WBC levels and covariates of interest. The CRP levels were 
raised in black, older and male participants, whereas, WBC count were higher in younger, male 
and races other than black. The levels of both biomarkers were elevated in current smokers, 
lower education and presence of history of any CVD, rheumatoid arthritis, chronic obstructive 
pulmonary disease, and recent infections. 
In single pollutant PM2.5 models, there was an increased response of change in CRP in 
participants who had MetS compared to those who did not have MetS, for both short and long 
term exposure, after adjusting for age, gender, race, education, smoking status, history of any 
cardiovascular disease, and maximum apparent temperature. The increased response was greater 
for long term exposure. In bi-pollutant models (i.e., adjusting for ozone), there was a significant 
positive association of lag 0 PM2.5 for participants with MetS. For every 10 µg/m3change in 
PM2.5, there was a change of 10.1% (2.2%-18.6%) for CRP. Also, for other lags, there was an 
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increase in CRP in participants who had MetS compared to those who did not have MetS (Figure 
11).  
Similar to CRP, there was an increase in WBC count in participants who had MetS 
compared to those who did not have MetS, for both short and long term exposure in single 
pollutant PM2.5 models, after adjusting for age, gender, race, education, smoking status, history 
of any cardiovascular disease, and maximum apparent temperature. The increased response was 
more for long term exposure. In bi-pollutant models (i.e., adjusting for ozone), the point 
estimates were enhanced (Figure 12). 
Sensitivity Analysis. The results of sensitivity analyses excluding people with history of 
(a) rheumatoid arthritis; (b) chronic obstructive pulmonary disease; (c) acute infection in last 30 
days; (d) household smoking were largely similar.  Additionally, adjusting for season and year 
led to similar results (Data not shown). 
5.5 DISCUSSION 
Our objective was to examine the association of PM2.5 air pollution exposure with biomarkers, 
i.e., CRP and WBC, of cardiovascular risk in adult NHANES participants with MetS compared 
to participants without MetS. We found that participants with MetS had an increased response of 
change in biomarkers of cardiovascular risk to increase in PM2.5 air pollution compared to 
participants without MetS. 
Our study supports previous evidence that preexisting cardio metabolic diseases may 
confer susceptibility to particle-induced systemic inflammation. Previous epidemiological 
studies have found stronger effects of air pollution on inflammatory markers among diabetics 
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[21, 30, 49] and the obese [19]. Controlled human exposure studies in MetS participants [112] 
found significant positive associations of CRP to particle air pollution compared to studies in 
healthy adults [113-115].  
However, there are a few studies that have examined the relationship of PM2.5 with CRP 
and WBC count before in people with MetS. Dubowsky et al.  2006 found consistently 
significant positive associations for moving averages of 1-7 days of  PM2.5 exposure by presence 
of diabetes, obesity individually or diabetes, obesity and hypertension together in a panel study 
of 44 elderly participants for CRP [30]. In the same study, there was non-significant increased 
response for WBC count. Using the NHANES data, a study reported a significant incremental 
change in WBC count to long term exposure of PM10 according to a number of MetS criteria. 
However, they utilized NHANES III (1989-1994) participants who lived  in urban areas, and the 
pollutant data from US EPA Air Quality System monitors PM10 levels during this earlier time 
period (1989-1994) were significantly higher (1 year average PM10 = 36.8 ±13 µg/m3).  
The stronger associations of PM2.5 exposure with biomarkers of cardiovascular risk in 
MetS participants, who are already at higher risk of CVD, are likely due to already primed 
cellular machinery for the generation of excess reactive oxygen species and proinflammatory 
responses [116]. Animal studies have shown dysregulation of normal cardiac, vascular, and 
autonomic responses to inhalation exposure of O3 and PM2.5 in rats with high fructose diet 
induced MetS [117]. 
To our knowledge, this is the first nationwide population-based study examining the 
association of short and long-term exposure to PM2.5 air pollution with inflammatory biomarkers 
of cardiovascular risk. The PM2.5 exposure was assessed by using pollutant predictions at the 
population weighted centroid of the census tract using downscaling model approach from EPA 
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[93].  This approach allows use of health data for nearly the entire country instead of being 
limited to urban areas due to its ability to predict air pollutant concentrations for a large spatial 
extent and makes study findings generalizable to the US.  Additionally, it better predicts 
temporal variability indicative of air pollutant concentrations measured at air quality monitors 
compared with earlier CMAQ models and spatial interpolation methods [93, 103]. Our study was 
able to consider health effects at the lower end of ambient particulate matter exposure compared 
to previous studies [54] . As a result, this investigation suggests that even at a low level of air 
pollution, those with multiple pre-existing cardiovascular risk factors might have an increased 
risk of cardiovascular disease when exposed to particulate matter air pollution.  
This study must be interpreted in the context of its known limitations. There is a potential 
of exposure misclassification due to less confidence in the pollutant predictions in rural areas 
because of the increasing distance of these locations from air quality monitors [103]. 
Additionally, there is a possibility of error in exposure measurement due to use of average 
population exposure rather than individual exposure estimates and not accounting for the time 
spent indoors vs outdoors by the participants.   
 
Conclusion 
In summary, participants with MetS, compared to participants without MetS, showed a stronger 
positive response in systemic inflammation, as manifested by CRP and WBC count, in 
association with particulate air pollution (both short term and long term).With one third of the 
U.S. population meeting criteria for MetS, the health impact of particulate air pollutant in this 
sensitive population has the potential to be significant. 
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 Table 8. Distribution of environmental variables 
Year N PM2.5(µg/m3) O3 (ppb) Temperature (° C) 
2001 812 11.00±0.76 41.48±1.79 23.57±1.47 
2002 922 12.60±1.66 47.00±3.54 23.27±1.27 
2003 799 12.20±0.91 43.18±2.21 21.76±0.93 
2004 859 11.38±0.92 38.93±1.72 22.39±1.59 
2005 766 11.78±0.83 42.70±2.60 21.04±1.32 
2006 832 10.81±0.73 39.56±1.69 21.25±1.09 
2007 1054 12.80±1.61 44.35±3.25 21.78±1.97 
2008 1090 11.51±0.75 43.03±2.19 22.22±1.20 
2001-2008 7134 11.74±0.37 42.47±0.98 22.14±0.48 
*Values are mean ± SE 
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Table 9. Survey weighted descriptive statistics of biomarkers for non-pregnant adult participants with 
information available on all five criteria of metabolic syndrome 
 C - reactive protein White blood cells count 
 
n (%) 
Mean±SE  
(mg/dL) n (%) 
Mean ± SE (103  
cells/µL) 
Overall 7134(100) 0.4±0.01) 7123(100) 6.78± 0.04 
Age (years) 
  20-39 
  40-59 
  60+ 
 
2302(38.6) 
2321(39.3) 
2511(22.2) 
 
0.35±0.02 
0.42±0.02 
0.46±0.02 
 
2299(38.5) 
2318(39.3) 
2506(22.2 
 
6.85±0.05 
6.73±0.05 
6.77±0.08 
Gender 
  Male 
  Female 
 
3651(49.6) 
3483(50.4) 
 
0.34±0.01 
0.47±0.01 
 
3645(49.7) 
3478(50.3) 
 
6.83±0.05 
6.74±0.05 
Race/Ethnicity 
  White 
  Black 
  Hispanic 
  Others 
 
3722(72.4) 
1363(10.9) 
1381(7.6) 
668(9.1) 
 
0.39±0.01 
0.50±0.02 
0.41±0.02 
0.39±0.04 
 
3717(72.4) 
1362(10.8) 
1380(7.6) 
664(9.1) 
 
6.84±0.05 
6.25±0.06 
6.85±0.07 
6.89±0.09 
Education 
  1-11th grade 
  HS grad/GED or    some 
college 
  College graduate 
 
1993(17.8) 
3708(56.4) 
1433(25.8) 
 
0.44±0.02 
0.43±0.02 
0.32±0.02 
 
1987(17.8) 
3704(56.5) 
1432(25.7) 
 
7.12±0.08 
6.87±0.05 
6.37±0.05 
Smoking 
  Never 
  Former 
  Current 
 
3653(51.1) 
1894(24.6) 
1587(24.3) 
 
0.38±0.02 
0.41±0.02 
0.45±0.02 
 
3645(51.1) 
1891(24.6) 
1587(24.4) 
 
6.38±0.03 
6.56±0.07 
7.85±0.07 
History of any CVD  
  Yes 
  No 
 
801(8.2) 
6333(91.9) 
 
0.56±0.05 
0.39±0.01 
 
798(8.2) 
6325(91.9) 
 
7.19±0.12 
6.75±0.04 
Recent Infection  
  Yes 
  No 
 
1904(27.1) 
4981(72.9) 
 
0.54±0.03 
0.36±0.01 
 
1903(27.1) 
4972(72.9) 
 
7.02±0.06 
6.69±0.05 
Rheumatoid Arthritis 
 Yes 
 No 
 
369(4.01) 
6754(96.0) 
 
0.57±0.04 
0.40±0.01 
 
367(4.0) 
6745(96.0) 
 
7.10±0.16 
6.77±0.04 
COPD 
  Yes 
  No 
 
538(7.4) 
6574(92.6) 
 
0.65±0.06 
0.38±0.01 
 
539(7.5) 
6562(92.6) 
 
7.27±0.11 
6.74±0.04 
Household Smoker 
  Yes 
  No 
 
1376(20.3) 
5711(79.7) 
 
0.47±0.03 
0.39±0.01 
 
1376(20.3) 
5700(79.7) 
 
7.67±0.08 
6.56±0.03 
Abbreviations: CVD, cardiovascular diseases  
* excludes participants with missing data on CRP and WBC levels and covariates of interest 
 78 
 
Figure 11. (a) Effect Modification of associations between PM2.5 and C - reactive protein (CRP) by metabolic 
syndrome. Models are adjusted for age, gender, race/ethnicity, education, smoking status, history of 
cardiovascular disease, and maximum apparent temperature. (b) Models were also adjusted for the same lag 
ozone. 
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Figure 12. (a)  Effect Modification of associations between PM2.5 and White Blood Cell (WBC) counts by 
metabolic syndrome. Models are adjusted for age, gender, race/ethnicity, education, smoking status, history 
of cardiovascular disease, and maximum apparent temperature. (b) Models were also adjusted for the same 
lag ozone. 
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6.0  SUMMARY AND PUBLIC HEALTH SIGNIFICANCE 
Short term exposure to ambient PM2.5 air pollution was significantly associated with CVDs 
mortality, specifically, IHD and PVD, in Allegheny County, PA. The risk of IHD mortality due 
to PM2.5 air pollution was significantly greater for individuals who died outside of a hospital or 
nursing home compared to deaths in the hospital or nursing home. This could be due to exposure 
to high level of air pollution outside of hospital or nursing home, difficulty in accessing timely 
health care leading to significantly higher effect of air pollution on CVD/ IHD mortality or may 
be due to more accurate exposure assessment based on spatiotemporal kriging method at zip 
code of residence. This needs to be explored further. To understand the biological pathway 
linking PM2.5 exposure with CVDs, a nationwide representative sample of adult men and women 
was utilized. Suggestive evidence of stronger associations of PM2.5 with biomarkers of 
cardiovascular risk i.e. CRP, WBC count, homocysteine and fibrinogen, in participants with 
elements of MetS e.g. obesity, diabetes, hypertension and smokers were observed. Further 
investigation showed a stronger positive response in systemic inflammation, as manifested by 
CRP and WBC count in association with particulate air pollution (both short term and long 
term), in participants with MetS, compared to participants without MetS. With one third of the 
U.S. population meeting criteria for MetS, the health impact of particulate air pollutant in this 
sensitive population has the potential to be significant. 
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